0001144204-11-051304.txt : 20110906 0001144204-11-051304.hdr.sgml : 20110905 20110906102548 ACCESSION NUMBER: 0001144204-11-051304 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 7 CONFORMED PERIOD OF REPORT: 20110902 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant ITEM INFORMATION: Unregistered Sales of Equity Securities ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20110906 DATE AS OF CHANGE: 20110906 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HealthWarehouse.com, Inc. CENTRAL INDEX KEY: 0000754813 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-DRUG STORES AND PROPRIETARY STORES [5912] IRS NUMBER: 222413505 STATE OF INCORPORATION: DE FISCAL YEAR END: 1202 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-13117 FILM NUMBER: 111074882 BUSINESS ADDRESS: STREET 1: 100 COMMERCE BOULEVARD CITY: CINCINNATI, STATE: OH ZIP: 45140 BUSINESS PHONE: (513) 618-0911 MAIL ADDRESS: STREET 1: 100 COMMERCE BOULEVARD CITY: CINCINNATI, STATE: OH ZIP: 45140 FORMER COMPANY: FORMER CONFORMED NAME: HealthWarehouse, Inc. DATE OF NAME CHANGE: 20090818 FORMER COMPANY: FORMER CONFORMED NAME: CLACENDIX, INC. DATE OF NAME CHANGE: 20080107 FORMER COMPANY: FORMER CONFORMED NAME: ION NETWORKS INC DATE OF NAME CHANGE: 19990413 8-K 1 v234141_8k.htm FORM 8-K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.  20549
 

 
FORM 8-K
 
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 
Date of Report (Date of earliest event reported): September 2, 2011
 
HealthWarehouse.com, Inc.
(Exact Name of Registrant as Specified in Charter)
 
Delaware
 
0-13117
 
22-2413505
(State or other jurisdiction
 
(Commission File Number)
 
(IRS Employer
of incorporation)
     
Identification No.)

7107 Industrial Road
   
Florence, Kentucky
 
42042
(Address of principal executive offices)
 
(Zip Code)

Registrant’s telephone number, including area code:  (513) 618-0911


(Former name or former address, if changed since last report)

     
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
¨  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
¨  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 DFR 240.14a-12)
 
¨  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
¨  Pre-commencement communications pursuant to Rule 13e-4 (c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 
 
Item 1.01 Entry Into A Material Definitive Agreement.

On September 2, 2011, HealthWarehouse.com, Inc. and its wholly-owned subsidiaries, Hwareh.com, Inc. and Hocks.com, Inc. (together, the “Company”) entered into a Loan and Security Agreement (the “Loan Agreement”) with HWH Lending LLC, a Delaware limited liability company, and Milfam I, L.P., a Georgia limited partnership (the “Lenders”).  Under the terms of the Loan Agreement, on September 2, 2011, the Company borrowed $1,500,000 from each Lender (the “Loans”), or a total of $3,000,000.  The proceeds of the Loans will be used by the Company to purchase all of the outstanding shares of the Company’s $0.001 par value common stock (“Common Stock”) owned by Rock Castle Holdings, LLC, a more than 10% stockholder of the Company. The Loans will be evidenced by promissory notes (the “Notes”), and will bear interest at the rate of 7% per annum, payable at maturity.  The maturity date of each Loan is January 15, 2013.  The Loans may be prepaid in whole or in part at any time by the Company without penalty.

The Company granted the Lenders a first, priority security interest in all of the Company’s assets, in order to secure the Company’s obligation to repay the Loans. The Loan Agreement contains customary negative covenants restricting the Company’s ability to take certain actions without the Lenders’ consent, including incurring additional indebtedness, transferring or encumbering assets, paying dividends or making certain other payments, and acquiring other businesses.  Upon the occurrence of an Event of Default, the Lenders have the right to designate one of the Company’s directors until the Notes are paid in full or the default is cured. The payment of the Loans may be accelerated prior to their maturity dates upon certain specified events of default, including failure to pay, bankruptcy, breach of covenant, and breach of representations and warranties.

In consideration of the Loans, the Company granted each Lender a warrant to purchase 250,000 shares of Common Stock at a purchase price of $2.90 per share.  Each warrant may be exercised in whole or in part and from time to time for a term of five years from its grant date.  The warrants contain customary anti-dilution and purchase price adjustment provisions.  The warrants are transferable in whole or in part, so long as the transfers comply with applicable securities laws.

On September 2, 2011, the Company purchased 1,179,212 shares of its Common Stock from Rock Castle Holdings, LLC, a more than 10% stockholder of the Company (“Rock Castle”), which constituted all of the outstanding shares of Common Stock owned by Rock Castle.  The purchase price was $2.90 per share, or a total purchase price of $3,419,714.80.  The purchase was made under the terms of a Stock Purchase Agreement dated September 2, 2011, which contains customary representations, warranties and covenants of the parties (the “Purchase Agreement”).

The foregoing description of the Loan Agreement, the Notes, the warrants, and the Purchase Agreement is not intended to be complete and is qualified in its entirety by reference to the full text of the Loan Agreement, Notes, warrants, and Purchase Agreement, which are filed as Exhibits 4.1, 4.2, 4.3, 4.4, 10.1 and 10.2 hereto and are incorporated herein by reference.
  
 
 

 
 
Item 2.03.          Creation Of A Direct Financial Obligation Or An Obligation Under An Off- Balance Sheet Arrangement Of A Registrant.

See Item 1.01, which is incorporated herein by reference.

ITEM 3.02         Unregistered Sales of Equity Securities

See Item 1.01, which is incorporated herein by reference.

Item 9.01.           Financial Statements and Exhibits.
 
 
(d)
Exhibits.
     
 
4.1
Senior Secured Promissory Note dated September 2, 2011 in the principal amount of $1,500,000 payable by the Company to the order of HWH Lending, LLC.
     
 
4.2
Warrant to Purchase 250,000 Shares of the Common Stock of HealthWarehouse.com, Inc., dated September 2, 2011 and Issued to HWH Lending, LLC.
     
 
4.3
Senior Secured Promissory Note dated September 2, 2011 in the principal amount of $1,500,000 payable by the Company to the order of Milfam I, L.P.
     
 
4.4
Warrant to Purchase 250,000 shares of the Common Stock of Healthwarehouse.com, Inc. dated September 2, 2011 and issued to Milfam I, L.P.
     
 
10.1
Loan and Security Agreement dated September 2, 2011 among HealthWarehouse.com, Inc., Hwareh.com, Inc. and Hocks.com, Inc., as Borrowers, and HWH Lending LLC, and Milfam I, L.P., as Lenders.
     
 
10.2
Stock Purchase Agreement dated September 2, 2011 between the Company and Rock Castle Holdings, LLC.

 
 

 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
Date:    September 2, 2011
HEALTHWAREHOUSE.COM, INC.
     
 
By:
/s/ Lalit Dhadphale
   
Lalit Dhadphale
   
President and Chief Executive Officer
  
 
 

 
EX-4.1 2 v234141_ex4-1.htm EXHIBIT 4.1
EXHIBIT 4.1

THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT PURPOSES ONLY AND MAY NOT BE TRANSFERRED UNTIL (i) A REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”) SHALL HAVE BECOME EFFECTIVE WITH RESPECT THERETO OR (ii) RECEIPT BY THE BORROWERS OF AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE BORROWERS TO THE EFFECT THAT REGISTRATION UNDER THE ACT IS NOT REQUIRED IN CONNECTION WITH SUCH PROPOSED TRANSFER NOR IS IN VIOLATION OF ANY APPLICABLE STATE SECURITIES LAWS. THIS LEGEND SHALL BE ENDORSED UPON ANY NOTE ISSUED IN EXCHANGE FOR THIS NOTE.

HEALTHWAREHOUSE.COM, INC.
HWAREH.COM, INC.
HOCKS.COM, INC.

7% Senior Secured Promissory Note

$1,500,000.00
As of September 2, 2011

FOR VALUE RECEIVED, Healthwarehouse.com, Inc., a Delaware corporation (“Parent”), HWAREH.com, Inc. a Delaware corporation (“Subsidiary 1”) and Hocks.com, Inc., an Ohio corporation (“Subsidiary 2” and, collectively with Parent, the “Borrowers”) with principal executive offices at 7107 Industrial Blvd., Florence, KY 42042, jointly and severally promise to pay to the order of HWH Lending, LLC (the “Holder”), or registered assigns on January 15, 2013 (the “Maturity Date”), the principal amount of One Million Five Hundred Thousand dollars ($1,500,000.00) (the “Principal Amount”) in such coin or currency of the United States of America as at the time of payment shall be legal tender for the payment of public and private debts. Interest on this Note shall accrue on the Principal Amount outstanding at a rate equal to seven percent (7%) per annum and shall be payable on the Maturity Date.  Nothing in this paragraph shall be construed as the consent by the holder of this Note to any action otherwise prohibited by the terms of this Note or as a waiver of any such prohibition.  All capitalized terms used but not otherwise defined herein have the meanings given to them in the Loan Agreement (as hereinafter defined).

This Note is one of two Notes issued pursuant to that certain Loan and Security Agreement dated as of September 2, 2011, by and between Parent, Subsidiary 1, Subsidiary 2, Milfam I L.P. and the Holder (the “Loan Agreement”).  Reference is hereby made to the Loan Agreement for a statement of all of the terms and conditions under which the Loan evidenced hereby is made and is to be repaid and of the Collateral securing the Borrowers’ obligations hereunder.

Each payment by the Borrowers pursuant to this Note shall be made without set-off or counterclaim and in immediately available funds.
 
 
 

 
 
Each Borrower (i) waives presentment, demand, protest or notice of any kind in connection with this Note and (ii) agrees, in the event of an Event of Default, to pay to the Holder of this Note, on demand, all costs and expenses (including legal fees and expenses) incurred in connection with the enforcement and collection of this Note.

Notwithstanding any provision to the contrary contained herein, this Note is subject and entitled to certain terms, conditions, covenants and agreements contained in the Loan Agreement. Any transferee of this Note, by its acceptance hereof, assumes the obligations of the Holder in the Loan Agreement with respect to the conditions and procedures for transfer of this Note.  Reference to the Loan Agreement shall in no way impair the absolute and unconditional obligation of the Borrowers to pay both principal hereof and interest hereon as provided herein.

Additional agreements between the Borrowers and the Holder:

A.          All covenants, agreements and undertakings in this Note binding upon the Borrowers or the Holder shall bind and inure to the benefit of the successors and permitted assigns of the Borrowers and the Holder, respectively, whether so expressed or not.

B.          The Borrowers and the Holder hereby expressly and irrevocably agree that this Note shall be governed by and construed solely and exclusively in accordance with the laws of the State of New York without regard to the conflicts of laws principles thereof.  The Borrowers and the Holder hereby expressly and irrevocably agree that any suit or proceeding arising directly and/or indirectly pursuant to or under this instrument or the consummation of the transactions contemplated hereby, shall be brought solely in a federal or state court located in the City, County and State of New York. By its execution hereof, the parties hereby covenant and irrevocably submit to the inpersonam jurisdiction of the federal and state courts located in the City, County and State of New York and agrees that any process in any such action may be served upon any of them personally, or by certified mail or registered mail upon them or their agent, return receipt requested, with the same full force and effect as if personally served upon them in New York City. The parties hereto waive any claim that any such jurisdiction is not a convenient forum for any such suit or proceeding and any defense or lack of in personam jurisdiction with respect thereto.

C.           All notices and other communications from the Borrowers to the Holder of this Note shall be mailed by first class, registered or certified mail, postage prepaid, and/or a nationally recognized overnight courier service to the Holder’s address listed in Section 8.3 of the Loan Agreement or such other address furnished to the Borrowers in writing by the Holder.

D.          THE HOLDER AND THE BORROWERS HEREBY KNOWINGLY, VOLUNTARILY AND INTENTIONALLY WAIVE ANY RIGHTS THEY MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LITIGATION BASED HEREON, OR ARISING OUT OF, UNDER, OR IN CONNECTION WITH, THIS NOTE OR ANY OTHER DOCUMENT OR INSTRUMENT EXECUTED AND DELIVERED IN CONNECTION HEREWITH, OR ANY COURSE OF CONDUCT, COURSE OF DEALING, STATEMENTS (WHETHER VERBAL OR WRITTEN), OR ACTIONS OF THE HOLDER OR THE BORROWERS. THIS PROVISION IS A MATERIAL INDUCEMENT FOR THE HOLDER’S PURCHASE OF THIS NOTE.
 
 
 

 
 
E.           Upon an Event of Default, the Holder of this Note shall have all of the rights set forth in section of the Loan Agreement titled “Events of Default” which is incorporated herein by reference.

F.           No terms of this Note may be amended, waived or modified except by the express written consent of the Borrowers and the Holder.

G.          All the covenants, agreements, representations and warranties contained in this Note shall bind the parties hereto and their respective heirs, executors, administrators, distributes, successors, assigns, and transferees.
 
[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]
 
 
 

 
 
IN WITNESS WHEREOF, this Note has been executed and delivered on the date specified above by the duly authorized representatives of the Borrowers.
 
 
HEALTHWAREHOUSE.COM, INC.
     
 
By:
/s/ Lalit Dhadphale
   
Lalit Dhadphale
   
President and CEO

 
HWAREH.COM, INC.
     
 
By:
/s/ Lalit Dhadphale
   
Lalit Dhadphale
   
President and CEO

 
HOCKS.COM, INC.
     
 
By:
/s/ Lalit Dhadphale
   
Lalit Dhadphale
   
President and CEO
 
 
 

 
EX-4.2 3 v234141_ex4-2.htm EXHIBIT 4.2

EXHIBIT 4.2

EXECUTION COPY

NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL, IN A FORM REASONABLY ACCEPTABLE TO THE COMPANY, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR (II) UNLESS SOLD PURSUANT TO RULE 144 OR RULE 144A UNDER SAID ACT. NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES.
 

HealthWarehouse.com, Inc.
 
FORM OF COMMON STOCK PURCHASE WARRANT
 
Number of shares:
 
250,000
     
Holder:
 
HWH Lending, LLC
     
Grant Date:
 
September 2, 2011
     
Expiration Date:
 
September 2, 2016
     
Exercise Price per
Share:
 
$2.90 (Two and 90/100 dollars per share)
 
HealthWarehouse.com, Inc., a corporation organized and existing under the laws of the State of Delaware (the “Company”), hereby certifies that, for value received, HWH Lending, LLC, or its registered assigns or permitted transferees (the “Warrant Holder”), is entitled, subject to the terms set forth below, to purchase from the Company 250,000 shares, as adjusted from time to time as provided in Section 6 hereof, of common stock, $0.001 par value (the “Common Stock”), of the Company (each such share, a “Warrant Share” and all such shares, the “Warrant Shares”) at a price of $2.90 (two and 90/100 dollars) per Warrant Share (the “Exercise Price”), at any time and from time to time from and after the date hereof and through and including 5:00 p.m. New York City time on September 2, 2016 (the “Expiration Date”), and subject to the following terms and conditions.  This Warrant is being issued to the Holder pursuant to that certain Loan and Security Agreement, dated as of September 2, 2011, by and between the Company and the Holder (the “Loan Agreement”).  All capitalized terms used but not otherwise defined herein have the meanings given to them in the Loan Agreement.
 
1.               Registration of Warrant.  The Company shall register this Warrant upon records to be maintained by the Company for that purpose (the “Warrant Register”), in the name of the record Warrant Holder hereof from time to time.  The Company may deem and treat the registered Warrant Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Warrant Holder, and for all other purposes, and the Company shall not be affected by notice to the contrary.
 
2.               Investment Representation.  The Warrant Holder by accepting this Warrant represents that the Warrant Holder is acquiring this Warrant for its own account or the account of an accredited investor affiliate for investment purposes and not with the view to any offering or distribution and that the Warrant Holder will not sell or otherwise dispose of this Warrant or the underlying Warrant Shares in violation of applicable securities laws.  Subject to Section 10 hereof, the Warrant Holder acknowledges that the certificates representing any Warrant Shares will bear a legend indicating that they have not been registered under the United States Securities Act of 1933, as amended (the “1933 Act”) and may not be sold by the Warrant Holder except pursuant to an effective registration statement or pursuant to an exemption from registration requirements of the 1933 Act and in accordance with federal and state securities laws. 
 
 
 

 

3.               Validity of Warrant and Issue of Shares.  The Company represents and warrants that this Warrant has been duly authorized and validly issued and warrants and agrees that all of Common Stock that may be issued upon the exercise of the rights represented by this Warrant will, when issued upon such exercise, be duly authorized, validly issued, fully paid and nonassessable and free from all taxes, liens and charges with respect to the issue thereof.  The Company further warrants and agrees that during the period within which the rights represented by this Warrant may be exercised, the Company will at all times have authorized and reserved a sufficient number of Common Stock to provide for the exercise of the rights represented by this Warrant.
 
4.               Registration of Transfers and Exchange of Warrants.
 
a.  All or any portion of this Warrant shall be assignable or transferable by Warrant Holder to a subsidiary, parent, general partner, limited partner, retired partner, affiliate, member or retired member, or stockholder of a Holder that is a corporation, partnership or limited liability company,  subject to such terms and conditions with respect to such assignment or transfer as Warrant Holder shall determine.
 
b.  Subject to compliance with the legend set forth on the face of this Warrant, the Company shall register the transfer of any portion of this Warrant in the Warrant Register, upon surrender of this Warrant with the Form of Assignment attached hereto duly completed and signed, to the Company at the office specified in or pursuant to Section 12.  Upon any such registration or transfer, a new warrant to purchase Common Stock, in substantially the form of this Warrant (any such new warrant, a “New Warrant”), evidencing the portion of this Warrant so transferred shall be issued to the transferee and a New Warrant evidencing the remaining portion of this Warrant not so transferred, if any, shall be issued to the transferring Warrant Holder.  The acceptance of the New Warrant by the transferee thereof shall be deemed the acceptance of such transferee of all of the rights and obligations of a Warrant Holder of a Warrant.
 
c.  This Warrant is exchangeable, upon the surrender hereof by the Warrant Holder to the office of the Company specified in or pursuant to Section 12 for one or more New Warrants, evidencing in the aggregate the right to purchase the number of Warrant Shares which may then be purchased hereunder.  Any such New Warrant will be dated the date of such exchange.
 
5.               Exercise of Warrants.
 
a.  Upon surrender of this Warrant with the Form of Election to Purchase attached hereto duly completed and signed to the Company, at its address set forth in Section 12, and upon payment and delivery of the Exercise Price per Warrant Share multiplied by the number of Warrant Shares that the Warrant Holder intends to purchase hereunder, in lawful money of the United States of America, in cash or by certified or official bank check or checks, to the Company, all as specified by the Warrant Holder in the Form of Election to Purchase, the Company shall promptly (but in no event later than 7 business days after the Date of Exercise (as defined herein)) issue and deliver or cause to be issued  and cause to be delivered to or upon the written order of the Warrant Holder and in such name or names as the Warrant Holder may designate (subject to the restrictions on transfer described in the legend set forth on the face of this Warrant), a stock certificate for the number of Warrant Shares issuable upon such exercise, with such restrictive legend as required by the 1933 Act.  Any person so designated by the Warrant Holder to receive Warrant Shares shall be deemed to have become holder of record of such Warrant Shares as of the Date of Exercise.  In connection with such exercise, the Warrant Holder, or such person so designated by the Warrant Holder in accordance with this paragraph, shall be deemed a stockholder of record with respect to the Warrant Shares purchaser pursuant to such exercise, with all rights of a stockholder, including voting rights and rights to receive dividends.
 
 
 

 

b.          A “Date of Exercise” means the date on which the Company shall have received (i) this Warrant (or any New Warrant, as applicable), with the Form of Election to Purchase attached hereto (or attached to such New Warrant) appropriately completed and duly signed, and (ii) payment of the Exercise Price for the number of Warrant Shares so indicated by the Warrant Holder to be purchased.
 
c.          This Warrant shall be exercisable at any time and from time to time for such number of Warrant Shares as is indicated in the attached Form of Election To Purchase.  If less than all of the Warrant Shares which may be purchased under this Warrant are exercised at any time, the Company shall issue or cause to be issued, at its expense, a New Warrant evidencing the right to purchase the remaining number of Warrant Shares for which no exercise has been evidenced by this Warrant.
 
d.          Cashless Exercise. The Warrant Holder may, in its sole discretion, exercise this Warrant in whole or in part and, in lieu of making the cash payment otherwise contemplated to be made to the Company upon such exercise in payment of the aggregate Exercise Price, elect instead to receive upon such exercise the “Net Number” of shares of Common Stock determined according to the following formula (a “Cashless Exercise”):
 
Net Number =       (A x B) — (A x C)
  B
 
For purposes of the foregoing formula:
 
A = the total number of shares with respect to which this Warrant is then being exercised.
 
B = the closing sale price of the shares of Common Stock (as reported by Bloomberg) on the date immediately preceding the date of the Form of Election to Purchase (the “Closing Price”).
 
C = the Exercise Price then in effect for the applicable Warrant Shares at the time of such exercise.
 
e.          Deemed Exercise.  If, at the Expiration Date for any Warrant Shares, this Warrant has not theretofore been exercised with respect to such Warrant Shares, and the Closing Price on the business day immediately prior to the Expiration Date is greater than the Exercise Price, then the Warrant Holder shall be deemed to have exercised this Warrant in whole with respect to such Warrant Shares immediately prior to such Expiration Date and shall be deemed to have elected to pay the aggregate Exercise Price pursuant to paragraph d. (Cashless Exercise) of this Section 5, and the Date of Exercise with respect to such deemed exercise shall be the date on which such Expiration Date occurs.
 
6.               Adjustment of the Number of Shares.  The character of the shares of stock or other securities at the time issuable upon exercise of this Warrant, are subject to adjustment upon the occurrence of the following events, and all such adjustments shall be cumulative:
 
a.          Adjustment for Stock Splits, Stock Dividends, Recapitalizations, Etc.  The Exercise Price and the number of shares of Common Stock or other securities at the time issuable upon exercise of this Warrant shall be appropriately adjusted to reflect any stock dividend, stock split, combination of shares, reclassification, recapitalization or other similar event affecting the number of outstanding shares of stock or securities.
 
b.          Reserved
 
c.          Reserved
 
 
 

 

d.   Distributions of Other Property.  If, at any time while this Warrant  remains outstanding and unexpired with respect to any Warrant Shares, the Company shall distribute to all holders of Company Common Stock (including any such distribution made in connection with a consolidation or merger in which the Company is the continuing corporation) evidences of its indebtedness or assets (excluding ordinary cash dividends or distributions payable out of consolidated earnings or earned surplus and dividends or distributions referred to in paragraph (a) of this Section 6), then, in lieu of an adjustment to the number of shares Company Common Stock purchasable upon the exercise of this Warrant, the Warrant Holder, upon the exercise hereof at any time after such distribution shall be entitled to receive from the Company the stock or other securities to which the Warrant Holder would have been entitled if the Warrant Holder had exercised this Warrant immediately prior thereto, all subject to further adjustment as provided in this Section 6.        
 
e.   Certificate as to Adjustments.  In case of any adjustment or readjustment in the number or kind of securities issuable on the exercise of this Warrant, or the Exercise Price, the Company will promptly give written notice thereof (but in no event later than 5 business days thereafter) to the holder of this Warrant in the form of a certificate, certified and confirmed by the Board of Directors of the Company, setting forth such adjustment or readjustment and showing in reasonable detail the facts upon which such adjustment or readjustment is based.
 
7.               Fractional Shares.  The Company shall not be required to issue or cause to be issued fractional Warrant Shares on the exercise of this Warrant.  The number of full Warrant Shares that shall be issuable upon the exercise of this Warrant shall be computed on the basis of the aggregate number of Warrants Shares purchasable on exercise of this Warrant so presented.  If any fraction of a Warrant Share would, except for the provisions of this Section 7, be issuable on the exercise of this Warrant, the Company shall, at its option, (i) pay an amount in cash equal to the Exercise Price multiplied by such fraction or (ii) round the number of Warrant Shares issuable, up to the next whole number.
 
8.               Sale or Merger the Company.  The Company will give Warrant Holder 15-day written notice before the event of a sale of all or substantially all of the assets of the Company or the merger or consolidation of the Company in a transaction in which the Company is not the surviving entity (a “Fundamental Transaction”).  The Company shall not enter into or be party to such Fundamental Transaction unless the surviving entity assumes in writing all of the obligations of the Company under this Warrant pursuant to written agreements in form and substance satisfactory to the Warrant Holder and approved by the Warrant Holder prior to such Fundamental Transaction, including agreements to deliver to the Warrant Holder in exchange for this Warrant a security of the surviving entity evidenced by a written instrument substantially similar in form and substance to this Warrant, including, without limitation, an adjusted exercise price equal to the value for the shares of Common Stock reflected by the terms of such Fundamental Transaction, and exercisable for a corresponding number of shares of capital stock equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and satisfactory to the Warrant Holder.
 
9.               Issuance of Substitute Warrant.   In the event of a merger, consolidation, recapitalization or reorganization of the Company or a reclassification of Company shares of stock, which results in an adjustment to the number of shares subject to this Warrant hereunder, the Company agrees to issue to the Warrant Holder a substitute Warrant reflecting the adjusted number of shares upon the surrender of this Warrant to the Company.
 
10.              Listing of Shares.   The Company shall promptly secure the listing of all of the Warrant Shares issuable hereunder upon each national securities exchange and automated quotation system, if any, upon which the Common Stock is then listed (subject to official notice of issuance) and shall maintain, so long as any other shares of Common Stock shall be so listed, such listing of Warrant Shares.
 
 
 

 
 
11.              Noncircumvention. The Company hereby covenants and agrees that the Company will not, by amendment of its Certificate of Incorporation, Bylaws or through any reorganization, transfer of assets, consolidation, merger, scheme of arrangement, dissolution, issue or sale of securities, or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, and will at all times in good faith carry out all the provisions of this Warrant and take all action as may be required to protect the rights of the Warrant Holder. Without limiting the generality of the foregoing, the Company (i) shall not increase the par value of any shares of Common Stock receivable upon the exercise of this Warrant above the Exercise Price then in effect, (ii) shall take all such actions as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable shares of Common Stock upon the exercise of this Warrant, and (iii) shall take all action necessary to reserve and keep available out of its authorized and unissued shares of Common Stock, solely for the purpose of effecting the exercise of the this Warrant, 100% of the number of shares of Common Stock as shall from time to time be necessary to effect the exercise of this Warrant  (without regard to any limitations on exercise).
 
12.              Notice.  All notices and other communications hereunder shall be in writing and shall be deemed to have been given (i) on the date they are delivered if delivered in person; (ii) on the date initially received if delivered by facsimile transmission followed by registered or certified mail confirmation; (iii) on the date delivered by an overnight courier service; or (iv) on the third business day after it is mailed by registered or certified mail, return receipt requested with postage and other fees prepaid as follows:
 
 
If to the Company:
 
HealthWarehouse.com, Inc.
 
7107 Industrial Road
 
Florence, KY 42042
 
Fax: (866) 821-3784
 
Attn: Chief Executive Officer
   
 
with a copy (for informational purposes only) to:
   
 
Mark J. Zummo, Esq.
 
Kohnen & Patton LLP
 
800 PNC Center
 
201 E. Fifth Street
 
Cincinnati, OH 45202
 
Telephone:  (513) 381-0656
 
Fax: (513) 381-5823
   
 
If to the Warrant Holder:
   
 
HWH Lending, LLC
 
2200 Fletcher Ave., 5th Floor
 
Fort Lee, NJ 07024
 
Tel:
 
Fax: (201) 224-2762
 
Attn:  Gary Singer
   
 
With a copy (for informational purposes only) to:
   
 
Edward T. Gilman
 
Andrews Kurth LLP
 
111 Congress Avenue, Suite 1700
 
Austin, TX 78701
 
Telephone: (512) 320-9266
 
Fax: (512) 542-5231

 
 

 

13.             Loss of Warrant.  Upon receipt by the Company of satisfactory evidence of loss, theft, destruction or mutilation of this Warrant and of indemnity satisfactory to the Company, and upon surrender and cancellation of this Warrant, if mutilated, the Company shall execute and deliver a new Warrant of like tenor and date and any such lost, stolen or destroyed Warrant shall thereupon become void.
 
14.             Miscellaneous.
 
a.  This Warrant shall be binding on and inure to the benefit of the parties hereto and their respective successors and permitted assigns.  This Warrant may be amended only in writing and signed by the Company and the Warrant Holder.
 
b.  Nothing in this Warrant shall be construed to give to any person or corporation other than the Company and the Warrant Holder any legal or equitable right, remedy or cause of action under this Warrant; this Warrant shall be for the sole and exclusive benefit of the Company and the Warrant Holder.
 
c.  This Warrant shall be governed by, construed and enforced in accordance with the internal laws of the State of Delaware without regard to the principles of conflicts of law thereof.  Each party irrevocably submits and consent to the exclusive jurisdictions of the United States District Courts of the State of Delaware, or, if such court does not have jurisdiction or will not accept jurisdiction, in any court of general jurisdiction in the State of Delaware, and hereby agrees that such courts shall be the exclusive proper forum for the determination of any dispute arising hereunder.
 
d.  The headings herein are for convenience only, do not constitute a part of this Warrant and shall not be deemed to limit or affect any of the provisions hereof.
 
e.  In case any one or more of the provisions of this Warrant shall be invalid or unenforceable in any respect, the validity and enforceability of the remaining terms and provisions of this Warrant shall not in any way be affected or impaired thereby and the parties will attempt in good faith to agree upon a valid and enforceable provision which shall be a commercially reasonably substitute therefore, and upon so agreeing, shall incorporate such substitute provision in this Warrant.
 
f.            The Warrant Holder shall not, by virtue hereof, be entitled to any voting or other rights of a shareholder of the Company, either at law or equity, and the rights of the Warrant Holder are limited to those expressed in this Warrant.
 
g.            The remedies provided in this Warrant shall be cumulative and in addition to all other remedies available under this Warrant, at law or in equity (including a decree of specific performance and/or other injunctive relief), and nothing herein shall limit the right of the Warrant Holder to pursue actual damages for any failure by the Company to comply with the terms of this Warrant. The Company acknowledges that a breach by it of its obligations hereunder will cause irreparable harm to the Warrant Holder and that the remedy at law for any such breach may be inadequate. The Company therefore agrees that, in the event of any such breach or threatened breach, the holder of this Warrant shall be entitled, in addition to all other available remedies, to an injunction restraining any breach, without the necessity of showing economic loss and without any bond or other security being required.  If any action, suit, or other proceedings is instituted concerning or arising out of this Warrant, the prevailing party shall recover all of such party’s costs and reasonable attorney’s fees incurred in each such action, suit, or other proceeding, including any and all appeals or petitions from any such action, suit or other proceeding.
 
h.            From and after the date of this Warrant, upon the request of the Warrant Holder or the Company, the Company and the Warrant Holder shall execute and deliver such instruments, documents or other writings as may be reasonably necessary or desirable to confirm and carry out and to effectuate fully the intent and purposes of this Warrant.
 
[SIGNATURE PAGE FOLLOWS]
 
 
 

 

IN WITNESS WHEREOF, the Company has caused this Warrant to be duly executed by the authorized officer as of the Grant Date first above stated.
 
Healthwarehouse.com, Inc.
 
By:
/s/ Lalit Dhadphale
Name:
Lalit Dhadphale, President

 
 

 

FORM  OF  ELECTION  TO  PURCHASE
 
(To be executed by the Warrant Holder to exercise the right to purchase shares of Common Stock under the foregoing Warrant)
 
To:  HealthWarehouse.com, Inc.
 
In accordance with the Warrant enclosed with this Form of Election to Purchase, the undersigned hereby irrevocably elects to purchase                          shares of Common Stock (“Common Stock”), $0.___ par value, of HealthWarehouse.com, Inc. and encloses one warrant and $                      for each Warrant Share being purchased or an aggregate of $                           in cash or certified or official bank check or checks, which sum represents the aggregate Exercise Price (as defined in the Warrant) together with any applicable taxes payable by the undersigned pursuant to the Warrant.
 
The undersigned requests that certificates for the shares of Common Stock issuable upon this exercise be issued in the name of:
 
   
   
   
   
   
(Please print name and address)
 
   
   
(Please insert Social Security or Tax Identification
Number)
 
 
If the number of shares of Common Stock issuable upon this exercise shall not be all of the shares of Common Stock which the undersigned is entitled to purchase in accordance with the enclosed Warrant, the undersigned requests that a New Warrant (as defined in the Warrant) evidencing the right to purchase the shares of Common Stock not issuable pursuant to the exercise evidenced hereby be issued in the name of and delivered to:
 
   
   
   
   
   
(Please print name and address)
 

 
Dated:
   
Name of Warrant Holder:
 
 
(Print)
 
     
 
(By:)
 
     
 
(Name:)
 
     
 
(Title:)
 
     
 
Signature must conform in all respects to name of Warrant
Holder as specified on the face of the Warrant

 
 

 

FORM OF ASSIGNMENT PURSUANT TO SECTION 4(a)
 
(To be executed by the registered holder if such holder desires to transfer the Warrant Certificate.)
 
FOR VALUE RECEIVED hereby sells, assigns and transfers unto
 
   
(Please print name and address of transferee)
 
 
this Warrant Certificate, together with all right, title and interest therein, and hereby irrevocably constitutes and appoints                                                         Attorney, to transfer the within Warrant Certificate on the books of the within-named Company, with full power of substitution.
 
Dated:
   
 
Signature:
   
     
 
(Signature must confirm in all respects to name of holder as specified on the face of the
Warrant Certificate.)
   
   
(Insert Social Security or Other Identifying Number of Assignee).
 
 
 

 
EX-4.3 4 v234141_ex4-3.htm EXHIBIT 4.3
EXHIBIT 4.3

THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT PURPOSES ONLY AND MAY NOT BE TRANSFERRED UNTIL (i) A REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”) SHALL HAVE BECOME EFFECTIVE WITH RESPECT THERETO OR (ii) RECEIPT BY THE BORROWERS OF AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE BORROWERS TO THE EFFECT THAT REGISTRATION UNDER THE ACT IS NOT REQUIRED IN CONNECTION WITH SUCH PROPOSED TRANSFER NOR IS IN VIOLATION OF ANY APPLICABLE STATE SECURITIES LAWS. THIS LEGEND SHALL BE ENDORSED UPON ANY NOTE ISSUED IN EXCHANGE FOR THIS NOTE.

HEALTHWAREHOUSE.COM, INC.
HWAREH.COM, INC.
HOCKS.COM, INC.

7% Senior Secured Promissory Note

$1,500,000.00
As of September 2, 2011

FOR VALUE RECEIVED, Healthwarehouse.com, Inc., a Delaware corporation (“Parent”), HWAREH.com, Inc. a Delaware corporation (“Subsidiary 1”) and Hocks.com, Inc., an Ohio corporation (“Subsidiary 2” and, collectively with Parent, the “Borrowers”) with principal executive offices at 7107 Industrial Blvd., Florence, KY 42042, jointly and severally promise to pay to the order of Milfam I L.P. (the “Holder”), or registered assigns on January 15, 2013 (the “Maturity Date”), the principal amount of One Million Five Hundred Thousand dollars ($1,500,000.00) (the “Principal Amount”) in such coin or currency of the United States of America as at the time of payment shall be legal tender for the payment of public and private debts. Interest on this Note shall accrue on the Principal Amount outstanding at a rate equal to seven percent (7%) per annum and shall be payable on the Maturity Date.  Nothing in this paragraph shall be construed as the consent by the holder of this Note to any action otherwise prohibited by the terms of this Note or as a waiver of any such prohibition.  All capitalized terms used but not otherwise defined herein have the meanings given to them in the Loan Agreement (as hereinafter defined).

This Note is one of two Notes issued pursuant to that certain Loan and Security Agreement dated as of September 2, 2011, by and between Parent, Subsidiary 1, Subsidiary 2, HWH Lending, LLC and the Holder (the “Loan Agreement”).  Reference is hereby made to the Loan Agreement for a statement of all of the terms and conditions under which the Loan evidenced hereby is made and is to be repaid and of the Collateral securing the Borrowers’ obligations hereunder.

Each payment by the Borrowers pursuant to this Note shall be made without set-off or counterclaim and in immediately available funds.
 
 
-1-

 
 
Each Borrower (i) waives presentment, demand, protest or notice of any kind in connection with this Note and (ii) agrees, in the event of an Event of Default, to pay to the Holder of this Note, on demand, all costs and expenses (including legal fees and expenses) incurred in connection with the enforcement and collection of this Note.

Notwithstanding any provision to the contrary contained herein, this Note is subject and entitled to certain terms, conditions, covenants and agreements contained in the Loan Agreement. Any transferee of this Note, by its acceptance hereof, assumes the obligations of the Holder in the Loan Agreement with respect to the conditions and procedures for transfer of this Note.  Reference to the Loan Agreement shall in no way impair the absolute and unconditional obligation of the Borrowers to pay both principal hereof and interest hereon as provided herein.

Additional agreements between the Borrowers and the Holder:

A.          All covenants, agreements and undertakings in this Note binding upon the Borrowers or the Holder shall bind and inure to the benefit of the successors and permitted assigns of the Borrowers and the Holder, respectively, whether so expressed or not.

B.          The Borrowers and the Holder hereby expressly and irrevocably agree that this Note shall be governed by and construed solely and exclusively in accordance with the laws of the State of New York without regard to the conflicts of laws principles thereof.  The Borrowers and the Holder hereby expressly and irrevocably agree that any suit or proceeding arising directly and/or indirectly pursuant to or under this instrument or the consummation of the transactions contemplated hereby, shall be brought solely in a federal or state court located in the City, County and State of New York. By its execution hereof, the parties hereby covenant and irrevocably submit to the inpersonam jurisdiction of the federal and state courts located in the City, County and State of New York and agrees that any process in any such action may be served upon any of them personally, or by certified mail or registered mail upon them or their agent, return receipt requested, with the same full force and effect as if personally served upon them in New York City. The parties hereto waive any claim that any such jurisdiction is not a convenient forum for any such suit or proceeding and any defense or lack of in personam jurisdiction with respect thereto.

C.          All notices and other communications from the Borrowers to the Holder of this Note shall be mailed by first class, registered or certified mail, postage prepaid, and/or a nationally recognized overnight courier service to the Holder’s address listed in Section 8.3 of the Loan Agreement or such other address furnished to the Borrowers in writing by the Holder.

D.          THE HOLDER AND THE BORROWERS HEREBY KNOWINGLY, VOLUNTARILY AND INTENTIONALLY WAIVE ANY RIGHTS THEY MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LITIGATION BASED HEREON, OR ARISING OUT OF, UNDER, OR IN CONNECTION WITH, THIS NOTE OR ANY OTHER DOCUMENT OR INSTRUMENT EXECUTED AND DELIVERED IN CONNECTION HEREWITH, OR ANY COURSE OF CONDUCT, COURSE OF DEALING, STATEMENTS (WHETHER VERBAL OR WRITTEN), OR ACTIONS OF THE HOLDER OR THE BORROWERS. THIS PROVISION IS A MATERIAL INDUCEMENT FOR THE HOLDER’S PURCHASE OF THIS NOTE.
 
 
-2-

 
 
E.           Upon an Event of Default, the Holder of this Note shall have all of the rights set forth in section of the Loan Agreement titled “Events of Default” which is incorporated herein by reference.

F.           No terms of this Note may be amended, waived or modified except by the express written consent of the Borrowers and the Holder.

G.          All the covenants, agreements, representations and warranties contained in this Note shall bind the parties hereto and their respective heirs, executors, administrators, distributes, successors, assigns, and transferees.
 
[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]
 
 
-3-

 
 
IN WITNESS WHEREOF, this Note has been executed and delivered on the date specified above by the duly authorized representatives of the Borrowers.
 
 
HEALTHWAREHOUSE.COM, INC.
     
 
By:
/s/ Lalit Dhadphale
   
Lalit Dhadphale
   
President and CEO

 
HWAREH.COM, INC.
     
 
By:
/s/ Lalit Dhadphale
   
Lalit Dhadphale
   
President and CEO

 
HOCKS.COM, INC.
     
 
By:
/s/ Lalit Dhadphale
   
Lalit Dhadphale
   
President and CEO
 
 
 

 
EX-4.4 5 v234141_ex4-4.htm EXHIBIT 4.4
EXHIBIT 4.4

EXECUTION COPY

NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL, IN A FORM REASONABLY ACCEPTABLE TO THE COMPANY, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR (II) UNLESS SOLD PURSUANT TO RULE 144 OR RULE 144A UNDER SAID ACT. NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES.
 

HealthWarehouse.com, Inc.
 
FORM OF COMMON STOCK PURCHASE WARRANT
 
Number of shares:
250,000
   
Holder:
Milfam I L.P.
   
Grant Date:
September 2, 2011
   
Expiration Date:
September 2, 2016
   
Exercise Price per
Share:
$2.90 (Two and 90/100 dollars per share)
 
HealthWarehouse.com, Inc., a corporation organized and existing under the laws of the State of Delaware (the “Company”), hereby certifies that, for value received, Milfam I L.P. (the “Warrant Holder”), is entitled, subject to the terms set forth below, to purchase from the Company 250,000 shares, as adjusted from time to time as provided in Section 6 hereof, of common stock, $0.001 par value (the “Common Stock”), of the Company (each such share, a “Warrant Share” and all such shares, the “Warrant Shares”) at a price of $2.90 (Two and 90/100 Dollars) per Warrant Share (the “Exercise Price”), at any time and from time to time from and after the date hereof and through and including 5:00 p.m. New York City time on September 2, 2016 (the “Expiration Date”), and subject to the following terms and conditions.  This Warrant is being issued to the Holder pursuant to that certain Loan and Security Agreement, dated as of September 2, 2011, by and between the Company and the Holder (the “Loan Agreement”).  All capitalized terms used but not otherwise defined herein have the meanings given to them in the Loan Agreement.
 
1.            Registration of Warrant.  The Company shall register this Warrant upon records to be maintained by the Company for that purpose (the “Warrant Register”), in the name of the record Warrant Holder hereof from time to time.  The Company may deem and treat the registered Warrant Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Warrant Holder, and for all other purposes, and the Company shall not be affected by notice to the contrary.
 
2.            Investment Representation.  The Warrant Holder by accepting this Warrant represents that the Warrant Holder is acquiring this Warrant for its own account or the account of an accredited investor affiliate for investment purposes and not with the view to any offering or distribution and that the Warrant Holder will not sell or otherwise dispose of this Warrant or the underlying Warrant Shares in violation of applicable securities laws.  Subject to Section 10 hereof, the Warrant Holder acknowledges that the certificates representing any Warrant Shares will bear a legend indicating that they have not been registered under the United States Securities Act of 1933, as amended (the “1933 Act”) and may not be sold by the Warrant Holder except pursuant to an effective registration statement or pursuant to an exemption from registration requirements of the 1933 Act and in accordance with federal and state securities laws. 
 
 

 
 
3.          Validity of Warrant and Issue of Shares.  The Company represents and warrants that this Warrant has been duly authorized and validly issued and warrants and agrees that all of Common Stock that may be issued upon the exercise of the rights represented by this Warrant will, when issued upon such exercise, be duly authorized, validly issued, fully paid and nonassessable and free from all taxes, liens and charges with respect to the issue thereof.  The Company further warrants and agrees that during the period within which the rights represented by this Warrant may be exercised, the Company will at all times have authorized and reserved a sufficient number of Common Stock to provide for the exercise of the rights represented by this Warrant.
 
 
4. 
Registration of Transfers and Exchange of Warrants.
 
a.  All or any portion of this Warrant shall be assignable or transferable by Warrant Holder to a subsidiary, parent, general partner, limited partner, retired partner, affiliate, member or retired member, or stockholder of a Holder that is a corporation, partnership or limited liability company,  subject to such terms and conditions with respect to such assignment or transfer as Warrant Holder shall determine.
 
b. Subject to compliance with the legend set forth on the face of this Warrant, the Company shall register the transfer of any portion of this Warrant in the Warrant Register, upon surrender of this Warrant with the Form of Assignment attached hereto duly completed and signed, to the Company at the office specified in or pursuant to Section 12.  Upon any such registration or transfer, a new warrant to purchase Common Stock, in substantially the form of this Warrant (any such new warrant, a “New Warrant”), evidencing the portion of this Warrant so transferred shall be issued to the transferee and a New Warrant evidencing the remaining portion of this Warrant not so transferred, if any, shall be issued to the transferring Warrant Holder.  The acceptance of the New Warrant by the transferee thereof shall be deemed the acceptance of such transferee of all of the rights and obligations of a Warrant Holder of a Warrant.
 
c. This Warrant is exchangeable, upon the surrender hereof by the Warrant Holder to the office of the Company specified in or pursuant to Section 12 for one or more New Warrants, evidencing in the aggregate the right to purchase the number of Warrant Shares which may then be purchased hereunder.  Any such New Warrant will be dated the date of such exchange.
 
 
5. 
Exercise of Warrants.
 
a.  Upon surrender of this Warrant with the Form of Election to Purchase attached hereto duly completed and signed to the Company, at its address set forth in Section 12, and upon payment and delivery of the Exercise Price per Warrant Share multiplied by the number of Warrant Shares that the Warrant Holder intends to purchase hereunder, in lawful money of the United States of America, in cash or by certified or official bank check or checks, to the Company, all as specified by the Warrant Holder in the Form of Election to Purchase, the Company shall promptly (but in no event later than 7 business days after the Date of Exercise (as defined herein)) issue and deliver or cause to be issued  and cause to be delivered to or upon the written order of the Warrant Holder and in such name or names as the Warrant Holder may designate (subject to the restrictions on transfer described in the legend set forth on the face of this Warrant), a stock certificate for the number of Warrant Shares issuable upon such exercise, with such restrictive legend as required by the 1933 Act.  Any person so designated by the Warrant Holder to receive Warrant Shares shall be deemed to have become holder of record of such Warrant Shares as of the Date of Exercise.  In connection with such exercise, the Warrant Holder, or such person so designated by the Warrant Holder in accordance with this paragraph, shall be deemed a stockholder of record with respect to the Warrant Shares purchaser pursuant to such exercise, with all rights of a stockholder, including voting rights and rights to receive dividends.
 
b.          A “Date of Exercise” means the date on which the Company shall have received (i) this Warrant (or any New Warrant, as applicable), with the Form of Election to Purchase attached hereto (or attached to such New Warrant) appropriately completed and duly signed, and (ii) payment of the Exercise Price for the number of Warrant Shares so indicated by the Warrant Holder to be purchased.
 
 

 
c.         This Warrant shall be exercisable at any time and from time to time for such number of Warrant Shares as is indicated in the attached Form of Election To Purchase.  If less than all of the Warrant Shares which may be purchased under this Warrant are exercised at any time, the Company shall issue or cause to be issued, at its expense, a New Warrant evidencing the right to purchase the remaining number of Warrant Shares for which no exercise has been evidenced by this Warrant.
 
d.          Cashless Exercise. The Warrant Holder may, in its sole discretion, exercise this Warrant in whole or in part and, in lieu of making the cash payment otherwise contemplated to be made to the Company upon such exercise in payment of the aggregate Exercise Price, elect instead to receive upon such exercise the “Net Number” of shares of Common Stock determined according to the following formula (a “Cashless Exercise”):
 
Net Number =       (A x B) — (A x C)
   B
 
For purposes of the foregoing formula:
 
A = the total number of shares with respect to which this Warrant is then being exercised.
 
B = the closing sale price of the shares of Common Stock (as reported by Bloomberg) on the date immediately preceding the date of the Form of Election to Purchase (the “Closing Price”).
 
C = the Exercise Price then in effect for the applicable Warrant Shares at the time of such exercise.
 
e.          Deemed Exercise.  If, at the Expiration Date for any Warrant Shares, this Warrant has not theretofore been exercised with respect to such Warrant Shares, and the Closing Price on the business day immediately prior to the Expiration Date is greater than the Exercise Price, then the Warrant Holder shall be deemed to have exercised this Warrant in whole with respect to such Warrant Shares immediately prior to such Expiration Date and shall be deemed to have elected to pay the aggregate Exercise Price pursuant to paragraph d. (Cashless Exercise) of this Section 5, and the Date of Exercise with respect to such deemed exercise shall be the date on which such Expiration Date occurs.
 
6.            Adjustment of the Number of Shares.  The character of the shares of stock or other securities at the time issuable upon exercise of this Warrant, are subject to adjustment upon the occurrence of the following events, and all such adjustments shall be cumulative:
 
a.          Adjustment for Stock Splits, Stock Dividends, Recapitalizations, Etc.  The Exercise Price and the number of shares of Common Stock or other securities at the time issuable upon exercise of this Warrant shall be appropriately adjusted to reflect any stock dividend, stock split, combination of shares, reclassification, recapitalization or other similar event affecting the number of outstanding shares of stock or securities.
 
b.          Reserved
 
c.           Reserved
 
d.   Distributions of Other Property.  If, at any time while this Warrant  remains outstanding and unexpired with respect to any Warrant Shares, the Company shall distribute to all holders of Company Common Stock (including any such distribution made in connection with a consolidation or merger in which the Company is the continuing corporation) evidences of its indebtedness or assets (excluding ordinary cash dividends or distributions payable out of consolidated earnings or earned surplus and dividends or distributions referred to in paragraph (a) of this Section 6), then, in lieu of an adjustment to the number of shares Company Common Stock purchasable upon the exercise of this Warrant, the Warrant Holder, upon the exercise hereof at any time after such distribution shall be entitled to receive from the Company the stock or other securities to which the Warrant Holder would have been entitled if the Warrant Holder had exercised this Warrant immediately prior thereto, all subject to further adjustment as provided in this Section 6.        
 
 

 
 
e.  Certificate as to Adjustments.  In case of any adjustment or readjustment in the number or kind of securities issuable on the exercise of this Warrant, or the Exercise Price, the Company will promptly give written notice thereof (but in no event later than 5 business days thereafter) to the holder of this Warrant in the form of a certificate, certified and confirmed by the Board of Directors of the Company, setting forth such adjustment or readjustment and showing in reasonable detail the facts upon which such adjustment or readjustment is based.
 
7.           Fractional Shares.  The Company shall not be required to issue or cause to be issued fractional Warrant Shares on the exercise of this Warrant.  The number of full Warrant Shares that shall be issuable upon the exercise of this Warrant shall be computed on the basis of the aggregate number of Warrants Shares purchasable on exercise of this Warrant so presented.  If any fraction of a Warrant Share would, except for the provisions of this Section 7, be issuable on the exercise of this Warrant, the Company shall, at its option, (i) pay an amount in cash equal to the Exercise Price multiplied by such fraction or (ii) round the number of Warrant Shares issuable, up to the next whole number.
 
8.            Sale or Merger the Company.  The Company will give Warrant Holder 15-day written notice before the event of a sale of all or substantially all of the assets of the Company or the merger or consolidation of the Company in a transaction in which the Company is not the surviving entity (a “Fundamental Transaction”).  The Company shall not enter into or be party to such Fundamental Transaction unless the surviving entity assumes in writing all of the obligations of the Company under this Warrant pursuant to written agreements in form and substance satisfactory to the Warrant Holder and approved by the Warrant Holder prior to such Fundamental Transaction, including agreements to deliver to the Warrant Holder in exchange for this Warrant a security of the surviving entity evidenced by a written instrument substantially similar in form and substance to this Warrant, including, without limitation, an adjusted exercise price equal to the value for the shares of Common Stock reflected by the terms of such Fundamental Transaction, and exercisable for a corresponding number of shares of capital stock equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and satisfactory to the Warrant Holder.
 
9.           Issuance of Substitute Warrant.   In the event of a merger, consolidation, recapitalization or reorganization of the Company or a reclassification of Company shares of stock, which results in an adjustment to the number of shares subject to this Warrant hereunder, the Company agrees to issue to the Warrant Holder a substitute Warrant reflecting the adjusted number of shares upon the surrender of this Warrant to the Company.
 
10.          Listing of Shares.   The Company shall promptly secure the listing of all of the Warrant Shares issuable hereunder upon each national securities exchange and automated quotation system, if any, upon which the Common Stock is then listed (subject to official notice of issuance) and shall maintain, so long as any other shares of Common Stock shall be so listed, such listing of Warrant Shares.
 
11.          Noncircumvention. The Company hereby covenants and agrees that the Company will not, by amendment of its Certificate of Incorporation, Bylaws or through any reorganization, transfer of assets, consolidation, merger, scheme of arrangement, dissolution, issue or sale of securities, or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, and will at all times in good faith carry out all the provisions of this Warrant and take all action as may be required to protect the rights of the Warrant Holder. Without limiting the generality of the foregoing, the Company (i) shall not increase the par value of any shares of Common Stock receivable upon the exercise of this Warrant above the Exercise Price then in effect, (ii) shall take all such actions as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable shares of Common Stock upon the exercise of this Warrant, and (iii) shall take all action necessary to reserve and keep available out of its authorized and unissued shares of Common Stock, solely for the purpose of effecting the exercise of the this Warrant, 100% of the number of shares of Common Stock as shall from time to time be necessary to effect the exercise of this Warrant  (without regard to any limitations on exercise).
 
 
 

 
12.           Notice.  All notices and other communications hereunder shall be in writing and shall be deemed to have been given (i) on the date they are delivered if delivered in person; (ii) on the date initially received if delivered by facsimile transmission followed by registered or certified mail confirmation; (iii) on the date delivered by an overnight courier service; or (iv) on the third business day after it is mailed by registered or certified mail, return receipt requested with postage and other fees prepaid as follows:
 
 
If to the Company:
   
 
HealthWarehouse.com, Inc.
 
7107 Industrial Road
 
Florence, KY 42042
 
Fax: (866) 821-3784
 
Attn: Chief Executive Officer
   
 
with a copy (for informational purposes only) to:
   
 
Mark J. Zummo, Esq.
 
Kohnen & Patton LLP
 
800 PNC Center
 
201 E. Fifth Street
 
Cincinnati, OH 45202
 
Telephone:  (513) 381-0656
 
Facsimile: (513) 381-5823
   
 
If to the Warrant Holder:
   
 
Milfam I L.P.
 
4550 Gordon Drive
 
Naples, FL 34102
 
Attn:  Lloyd I. Miller, III
 
Facsimile: (239) 262-8025
   
 
With a copy (for informational purposes only) to:
 
_________________________
 
_________________________
 
_________________________
 
_________________________
 
            13.            Loss of Warrant.  Upon receipt by the Company of satisfactory evidence of loss, theft, destruction or mutilation of this Warrant and of indemnity satisfactory to the Company, and upon surrender and cancellation of this Warrant, if mutilated, the Company shall execute and deliver a new Warrant of like tenor and date and any such lost, stolen or destroyed Warrant shall thereupon become void.
 
 
14. 
 Miscellaneous.
 
a.           This Warrant shall be binding on and inure to the benefit of the parties hereto and their respective successors and permitted assigns.  This Warrant may be amended only in writing and signed by the Company and the Warrant Holder.
 
b.           Nothing in this Warrant shall be construed to give to any person or corporation other than the Company and the Warrant Holder any legal or equitable right, remedy or cause of action under this Warrant; this Warrant shall be for the sole and exclusive benefit of the Company and the Warrant Holder.
 
 

 
 
c.         This Warrant shall be governed by, construed and enforced in accordance with the internal laws of the State of Delaware without regard to the principles of conflicts of law thereof.  Each party irrevocably submits and consent to the exclusive jurisdictions of the United States District Courts of the State of Delaware, or, if such court does not have jurisdiction or will not accept jurisdiction, in any court of general jurisdiction in the State of Delaware, and hereby agrees that such courts shall be the exclusive proper forum for the determination of any dispute arising hereunder.
 
d.         The headings herein are for convenience only, do not constitute a part of this Warrant and shall not be deemed to limit or affect any of the provisions hereof.
 
e.          In case any one or more of the provisions of this Warrant shall be invalid or unenforceable in any respect, the validity and enforceability of the remaining terms and provisions of this Warrant shall not in any way be affected or impaired thereby and the parties will attempt in good faith to agree upon a valid and enforceable provision which shall be a commercially reasonably substitute therefore, and upon so agreeing, shall incorporate such substitute provision in this Warrant.
 
f.          The Warrant Holder shall not, by virtue hereof, be entitled to any voting or other rights of a shareholder of the Company, either at law or equity, and the rights of the Warrant Holder are limited to those expressed in this Warrant.
 
g.          The remedies provided in this Warrant shall be cumulative and in addition to all other remedies available under this Warrant, at law or in equity (including a decree of specific performance and/or other injunctive relief), and nothing herein shall limit the right of the Warrant Holder to pursue actual damages for any failure by the Company to comply with the terms of this Warrant. The Company acknowledges that a breach by it of its obligations hereunder will cause irreparable harm to the Warrant Holder and that the remedy at law for any such breach may be inadequate. The Company therefore agrees that, in the event of any such breach or threatened breach, the holder of this Warrant shall be entitled, in addition to all other available remedies, to an injunction restraining any breach, without the necessity of showing economic loss and without any bond or other security being required.  If any action, suit, or other proceedings is instituted concerning or arising out of this Warrant, the prevailing party shall recover all of such party’s costs and reasonable attorney’s fees incurred in each such action, suit, or other proceeding, including any and all appeals or petitions from any such action, suit or other proceeding.
 
h.         From and after the date of this Warrant, upon the request of the Warrant Holder or the Company, the Company and the Warrant Holder shall execute and deliver such instruments, documents or other writings as may be reasonably necessary or desirable to confirm and carry out and to effectuate fully the intent and purposes of this Warrant.
 
[SIGNATURE PAGE FOLLOWS]
 
 

 
 
IN WITNESS WHEREOF, the Company has caused this Warrant to be duly executed by the authorized officer as of the Grant Date first above stated.
 
Healthwarehouse.com, Inc.
   
By:
/s/ Lalit Dhadphale
Name:
Lalit Dhadphale, President
 
 
 

 
FORM  OF  ELECTION  TO  PURCHASE
 
(To be executed by the Warrant Holder to exercise the right to purchase shares of Common Stock under the foregoing Warrant)
 
To:  HealthWarehouse.com, Inc.
 
In accordance with the Warrant enclosed with this Form of Election to Purchase, the undersigned hereby irrevocably elects to purchase                          shares of Common Stock (“Common Stock”), $0.___ par value, of HealthWarehouse.com, Inc. and encloses one warrant and $                      for each Warrant Share being purchased or an aggregate of $                           in cash or certified or official bank check or checks, which sum represents the aggregate Exercise Price (as defined in the Warrant) together with any applicable taxes payable by the undersigned pursuant to the Warrant.
 
The undersigned requests that certificates for the shares of Common Stock issuable upon this exercise be issued in the name of: 
 
   
   
   
   
   
(Please print name and address)
 
   
   
(Please insert Social Security or Tax Identification Number)
 
If the number of shares of Common Stock issuable upon this exercise shall not be all of the shares of Common Stock which the undersigned is entitled to purchase in accordance with the enclosed Warrant, the undersigned requests that a New Warrant (as defined in the Warrant) evidencing the right to purchase the shares of Common Stock not issuable pursuant to the exercise evidenced hereby be issued in the name of and delivered to:
 
   
   
   
   
   
(Please print name and address)
 
Dated:
   
Name of Warrant Holder:
     
 
(Print)
 
     
 
(By:)
 
     
 
(Name:)
 
     
 
(Title:)
 
   
 Signature must conform in all respects to name of Warrant Holder as specified on the face of the Warrant

 
 

 
 
FORM OF ASSIGNMENT PURSUANT TO SECTION 4(a)
 
(To be executed by the registered holder if such holder desires to transfer the Warrant Certificate.)
 
FOR VALUE RECEIVED hereby sells, assigns and transfers unto
 
   
(Please print name and address of transferee)
 
 
this Warrant Certificate, together with all right, title and interest therein, and hereby irrevocably constitutes and appoints                                                         Attorney, to transfer the within Warrant Certificate on the books of the within-named Company, with full power of substitution.
 
Dated:
   
 
Signature:
   
     
 
(Signature must confirm in all respects to name of holder as specified on the face of the Warrant Certificate.)
   
   
(Insert Social Security or Other Identifying Number of Assignee).
 
 
 

 
EX-10.1 6 v234141_ex10-1.htm EXHIBIT 10.1

EXHIBIT 10.1
 
LOAN AND SECURITY AGREEMENT
 
This LOAN AND SECURITY AGREEMENT is dated as of September 2, 2011, by and between Healthwarehouse.com, Inc., a Delaware corporation (“Parent”), HWAREH.com, Inc., a Delaware corporation (“Subsidiary 1”) and Hocks.com, Inc., an Ohio corporation (“Subsidiary 2” and, together with Parent and Subsidiary 1, each a “Borrower” and collectively, the “Borrowers”), HWH Lending LLC, a Delaware limited liability company (“HWH”), and Milfam I L.P., a Georgia limited partnership (“MIL”) each as lender (“Lender” and collectively, the “Lenders”).
 
RECITALS
 
WHEREAS, Borrowers desire that Lenders extend loans to Borrowers, the proceeds of which will be used by Borrowers to repurchase up to 1,180,212 shares (the “Shares”) of Parent’s common stock held by Rock Castle Holdings, LLC (“Stockholder”);
 
WHEREAS, Borrowers desire to secure their Obligations under the Loan Documents by granting to Lenders a Lien upon all of the Collateral of Borrowers; and
 
WHEREAS, the Borrowers and Lenders are Partners to a Loan and Security Agreement (the “Prior Agreement”) pursuant to which the Lenders loaned the Company an aggregate of $1,000,000 pursuant to two 7% Secured Promissory Notes dated November 8, 2010 (together, the “Prior Notes”).
 
NOW, THEREFORE, in consideration of the premises and the agreements, provisions and covenants herein contained, Borrowers and Lenders agree as follows:
 
SECTION 1
 
DEFINITIONS
 
1.1          Certain Defined TermsThe following terms used in this Agreement shall have the following meanings:
 
Accounts” means all of each Borrowers’ now existing and future accounts (as defined in the UCC).
 
Affiliate” means any Person (other than a Lender): (a) directly or indirectly controlling, controlled by, or under common control with any Borrower; (b) directly or indirectly owning, controlling or holding five percent (5%) or more of any equity interest in any Borrower; (c) five percent (5%) or more of whose voting stock or other equity interest having ordinary voting power for the election of directors or the power to direct or cause the direction of management, is directly or indirectly owned or held by any Borrower; or (d) which has a senior executive officer who is also a senior executive officer of any Borrower.  For purposes of this definition, “control” (including with correlative meanings, the terms “controlling”, “controlled by” and “under common control with”) means the possession directly or indirectly of the power to direct or cause the direction of the management and policies of a Person, whether through the ownership of voting securities or other equity interest, or by contract or otherwise.
 
 
 

 
 
Agreement” means this Loan and Security Agreement as amended, restated, supplemented or otherwise modified from time to time.
 
Asset Disposition” means the disposition, in any transaction or series of related transactions, whether by sale, lease (including any disposition in connection with a sale-lease back or synthetic lease transaction), transfer, loss, damage, destruction, condemnation or otherwise, of all, or substantially all, of the assets of any Borrower (whether such assets are now owned or hereafter acquired) or which has the effect of selling or otherwise disposing of the whole or a major part of the business or operations of any Borrower, in each case, whether or not consideration therefore consists of cash, securities or other assets owned by the acquiring Person, except where such disposition is made to an Affiliate of such Borrower.
 
Borrower” and “Borrowers” have the meanings assigned to such terms in the preamble to this Agreement.
 
Business Day” means any day excluding Saturday, Sunday and any day which is a legal holiday under the laws of the State of New York, or is a day on which banking institutions located in such state are permitted to be closed.
 
Capitalized Lease” means: (a) any lease of property, real or personal, if the then present value of the minimum rental commitment thereunder should, in accordance with GAAP, be capitalized on a balance sheet of Borrower, and (b) any other such lease, the obligations under which are capitalized on the balance sheet of any Borrower.
 
Capital Stock” means any and all capital stock, membership, partnership or other equity interests of each Borrower.
 
Change of Control” means  at any time, (i) the current shareholders of any Borrower shall cease to beneficially own and control, directly or indirectly on a fully diluted basis, fifty-one percent (51%) of the issued and outstanding Common Stock of such Borrower or (ii) any Person or group other than the current shareholders of any Borrower shall have the right to elect a majority of the seats on such Borrowers’ board of directors, but excluding any changes resulting from bona fide venture capital financing and public offerings of Capital Stock.
 
Closing Date” means September 2, 2011.
 
Collateral” means, collectively, any and all assets of any Borrower on which a Lien in favor of Lenders has been created and/or granted to secure the Obligations under the Loan Documents.
 
Commission” means the Securities and Exchange Commission.
 
Confidential Information” has the meaning assigned to that term in Section 8.14.
 
Default” means a condition, act or event that, after notice or lapse of time or both, would constitute an Event of Default.
 
 
-2-

 
 
Documents of Title” means all present and future documents (as defined in the UCC), and any and all warehouse receipts, bills of lading, shipping documents, chattel paper, instruments and similar documents, all whether negotiable or not and all goods and Inventory relating thereto and all cash and non-cash proceeds of the foregoing.
 
Employee Benefit Plan” means any employee benefit plan within the meaning of Section 3(3) of ERISA which (a) is maintained for employees of any Borrower or any ERISA Affiliate or (b) has at any time within the preceding six (6) years been maintained for the employees of any Borrower and/or any current or former ERISA Affiliate.
 
EPA” shall mean the United States Environmental Protection Agency and any governmental body or agency succeeding to the functions thereof.
 
Equipment” means all equipment, whether now owned or hereafter acquired (as defined in the UCC), including, without limitation (whether or not included in the UCC definition of “equipment”), all furniture, furnishings, fixtures, machinery, motor vehicles, trucks, trailers, vessels, aircraft and rolling stock and all parts thereof and all additions, accessories, motors, engines, and accessions thereto and replacements therefor and all cash and non-cash proceeds (as defined in the UCC) of any and all of the foregoing.
 
ERISA” means the Employee Retirement Income Security Act of 1974, as amended from time to time, and any successor statute and all rules and regulations promulgated thereunder.
 
ERISA Affiliate” as applied to any Borrower and its Subsidiaries, means any Person who is a member of a group which is under common control with such Borrower and its Subsidiaries, who together with such Borrower and its Subsidiaries is treated as a single employer within the meaning of Section 414(b) and (c) of the IRC.
 
Event of Default” means any of the events set forth in Section 7.1.
 
GAAP” means generally accepted accounting principles in effect from time to time in the United States, applied on a consistent basis.
 
General Intangibles” means all of each Borrowers’ “general intangibles” as defined in the UCC, now owned or hereafter acquired, including, without limitation (whether or not included in the UCC definition of “general intangibles”), all of such Borrowers’ then owned or existing and future acquired or arising general intangibles and causes of action and all other intangible personal property of such Borrower of every kind and nature, including, without limitation, Intellectual Property, corporate or other business records, inventions, designs, plans, specifications, trade secrets, goodwill, computer software, customer lists, licenses, franchises, tax refund claims, reversions or any rights thereto and any other amounts payable to such Borrower from any employee benefit plan, rights and claims against carriers and shippers, rights to indemnification, and business interruption, property, casualty or any similar type of insurance and any proceeds thereof, and all cash and non-cash proceeds (as defined in the UCC) of any and all of the foregoing.
 
 
-3-

 
 
Governmental Authority” means the government of the United States of America, any other nation or any political subdivision thereof, whether state or local, and any agency, authority, instrumentality, regulatory body, court, central bank or other entity exercising executive, legislative, judicial, taxing, regulatory or administrative powers or functions of or pertaining to government.
 
Indebtedness” means without duplication, with respect to each Borrower: (a) all obligations of Borrower for borrowed money, (b) all obligations of Borrower evidenced by bonds, debentures, notes or similar instruments, (c) all obligations of Borrower upon which interest charges are customarily paid, (d) all obligations of Borrower under conditional sale or other title retention agreements relating to property acquired by Borrower, (e) all obligations of Borrower in respect of the deferred purchase price of property or services (excluding current accounts payable incurred in the ordinary course of business and excluding installments of premiums payable with respect to policies of insurance contracted for in the ordinary course of business), (f) all Indebtedness of others secured by (or for which the holder of such Indebtedness has an existing right, contingent or otherwise, to be secured by) any Lien on property owned or acquired by Borrower, whether or not the Indebtedness secured thereby has been assumed, (g) all guaranties or endorsements by Borrower of others, (h) all obligations under Capitalized Leases of Borrower attributable to the payment of principal, (i) all obligations, contingent or otherwise, of Borrower as an account party in respect of letters of credit and letters of guaranty, and (j) all obligations, contingent or otherwise, of Borrower in respect of bankers’ acceptances.
 
Intellectual Property” means all present and future (a) designs, patents, patent rights and applications therefor, licenses rights, fees, and royalties with respect thereof; (b) trademarks, service marks, trade names and registrations and applications therefore, licenses, fees and royalties with respect thereof; (c) copyrights, renewals and all applications and registrations therefor, licenses, fees and royalties with respect thereof, (d) software or computer programs, trade secrets, methods, processes, know-how, drawings, specifications, and descriptions, and (e) all memoranda, notes and records with respect to any research and development, whether now owned or hereafter acquired, (f) all goodwill associated with any of the foregoing described in subsections (a) – (e), and proceeds of all of the foregoing, including, without limitation, proceeds of insurance policies thereon.
 
Inventory” means, with respect to each Borrower, all “inventory” as defined in the UCC including, without limitation (whether or not included in the UCC definition of “inventory”), all of Borrowers’ then owned or existing and future acquired or arising:  (a) inventory, merchandise, goods and other personal property intended for sale or lease or for display or demonstration; (b) inventory and any portion thereof that may be returned, rejected, reclaimed or repossessed by either Lenders or Borrower; (c) work in process; (d) raw materials and other materials and supplies, goods, incidentals, packaging materials and labels of every nature and description used or which might be used in connection with the manufacture, packing, shipping, advertising, selling, leasing or furnishing of the foregoing or otherwise used or consumed in the conduct of business; (e) documents evidencing, and General Intangibles relating to, any of the foregoing; and (f) all cash and non-cash proceeds (as defined in the UCC) of any and all of the foregoing.
 
 
-4-

 
 
Investment Property” means a security, whether certificated or uncertificated, security entitlement, securities account, commodity contract or commodity account.
 
IRC” means the Internal Revenue Code of 1986, as amended from time to time, and any successor statute and all rules and regulations promulgated thereunder.
 
Lender” has the meaning assigned to that term in the preamble to this Agreement.
 
Liabilities” shall have the meaning given that term in accordance with GAAP and shall include all Indebtedness.
 
Lien” means any lien (whether statutory or otherwise), mortgage, deed of trust, pledge, hypothecation, assignment, security interest, charge or encumbrance of any kind, whether voluntary or involuntary (including any conditional sale or other title retention agreement, any lease in the nature thereof, and any agreement to give any security interest).
 
Loan” means the unpaid balance of the Loan made pursuant to Section 2.1.
 
Loan Documents” means this Agreement, the Notes and all other instruments, documents, guaranties and agreements executed by or on behalf of either Borrower and delivered concurrently herewith or at any time hereafter to or for Lenders in connection with the Loan or any other transaction contemplated by this Agreement, all as amended, restated, supplemented or modified from time to time.
 
Material Adverse Effect” means, with respect to each Borrower, a material adverse effect upon (a) the businesses, operations, properties, assets or condition (financial or otherwise) of Borrower, (b) the ability of Borrower to perform its obligations under any Loan Document to which it is a party, (c) the value of the Collateral, or (d) the ability of any Lender to enforce or collect any of the Obligations.
 
Maturity Date” has the meaning assigned to such term in Section 2.3.
 
Note” means each of the 7% Senior Secured Promissory Notes of Borrowers, in the form attached hereto as Exhibit A, evidencing the Loans made by the Lenders to Borrowers pursuant to Section 2.1 hereof and any amendment and restatement thereof.
 
Obligations” means all obligations (including the full and faithful discharge of each and every term, condition, agreement, representation and warranty now or hereafter made by Borrowers under the Loan Documents), liabilities and indebtedness of every nature of Borrowers’ from time to time owed to Lenders under the Loan Documents including the principal amount of the Loan and accrued and unpaid interest, now and/or from time to time hereafter owing, due or payable.
 
Permitted Encumbrances” means the following types of Liens:
 
(A)           Liens securing the Obligations;
 
 
-5-

 
 
(B)           Liens for taxes, assessments or other governmental charges the payment of which is not yet due and payable or is being contested in good faith and by appropriate proceedings promptly initiated and diligently conducted, and a reserve or other appropriate provision, if any, as shall be required by GAAP shall have been made therefor, provided, that such liens shall have no effect on the priority of the Liens in favor of Lenders or the value of the assets in which Lenders have such Liens and a stay of enforcement of any such Liens shall be in effect;
 
(C)           Liens imposed by law, such as carrier’s, warehousemen’s, mechanic’s, materialmen’s and other similar Liens arising in the ordinary course of business and securing obligations (other than Indebtedness for borrowed money) that are not overdue by more than thirty (30) days or are being contested in good faith and by appropriate proceedings promptly initiated and diligently conducted, and a reserve or other appropriate provision, if any, as shall be required by GAAP shall have been made therefore, and, in the case of judgment Liens that have been stayed or bonded, a reserve or other appropriate provision, if any, as required by GAAP shall have been made therefor;
 
(D)           Liens arising under Capitalized Leases or securing purchase money Indebtedness in favor of a seller of Equipment, if and only if the Lien is confined to the property and improvements and the proceeds of the Equipment so purchased;
 
(E)           deposits and pledges of cash securing (i) obligations incurred in respect of workers’ compensation, unemployment insurance or other forms of governmental insurance or benefits, (ii) the performance of bids, tenders, leases (if the leases permit granting Lenders a security interest), contracts (other than for the payment of money) and statutory obligations or (iii) obligations on surety or appeal bonds, but only to the extent such deposits or pledges are incurred or otherwise arise in the ordinary course of business and secure obligations not past due;
 
(F)           easements, zoning restrictions and similar encumbrances on real property and minor irregularities in the title thereto that do not (i) secure obligations for the payment of money or (ii) materially adversely impair the value of such property or its use by Borrower in the normal conduct of its business; and
 
(G)           other Liens permitted to be incurred by Borrowers pursuant to the terms of this Agreement or any other Loan Document.
 
Permitted Indebtedness” means (i) Borrowers’ indebtedness to Lenders under this Agreement, the Prior Agreement or any of the other Loan Documents; (ii) Borrowers’ outstanding Indebtedness as of the date of this Agreement as listed on Schedule A hereto; (iii) indebtedness to trade creditors incurred in the ordinary course of business on ordinary trade terms and accrued expenses incurred in the ordinary course of business; (iv) indebtedness (including Capitalized Leases) incurred for the purpose of financing all or any part of the acquisition costs of Equipment; and (v) any extension, renewal or refinancing of the indebtedness described in clause (iv) above, provided that the principal amount and interest rate on such indebtedness may not be increased.
 
 
-6-

 
 
Person” means and includes natural persons, corporations, limited partnerships, general partnerships, limited liability companies, joint stock companies, joint ventures, associations, companies, trusts, banks, trust companies, land trusts, business trusts or other organizations, whether or not legal entities, and governments and agencies and political subdivisions thereof.
 
Prior Agreement” has the meaning assigned to such term in the recitals.
 
Prior Notes” has the meaning assigned to such term in the recitals.
 
Restricted Payment” means: (a) any redemption or repurchase of Capital Stock or Indebtedness of any Borrower now or hereafter outstanding, or the issuance of a notice of an intention to do any of the foregoing; provided, however, that repayment of Indebtedness in the ordinary course of business consistent with past practice shall not be considered a Restricted Payment hereunder; or (b) any payment made to retire, or to obtain the surrender of, any outstanding warrants, options or other rights to acquire shares of any class of the Capital Stock of any Borrower now or hereafter outstanding.
 
Returns” has the meaning assigned to such term in Section 4.15.
 
Securities Act” means the Securities Act of 1933, as amended.
 
Shares” has the meaning assigned to such term in the recitals.
 
Stockholder” has the meaning assigned to such term in the recitals.
 
Subsidiary” means, if applicable, with respect to any Person, any corporation, association or other business entity of which more than fifty percent (50%) of the total voting power of shares of stock, membership interests (or equivalent ownership or controlling interest) entitled (without regard to the occurrence of any contingency) to vote in the election of directors, managers or trustees thereof is at the time owned or controlled, directly or indirectly, by such Person (or any of its other Subsidiaries).
 
Subsidiary 1” has the meaning assigned to such term in the preamble to this Agreement.
 
Subsidiary 2” has the meaning assigned to such term in the preamble to this Agreement.
 
Taxes” means all federal, state, municipal and other governmental taxes, levies, charges, claims and assessments, and all interest, penalties and similar liabilities relating thereto, which are or may be due by Borrowers with respect to its business, operations, Collateral or otherwise.
 
UCC” means the Uniform Commercial Code as in effect on the date hereof in the State of New York, as amended from time to time, and any successor statute.
 
 
-7-

 
 
Warrants” means the Common Stock Purchase Warrants dated as of the date hereof issued by Parent to Lenders.
 
1.2          Accounting Terms.  For purposes of this Agreement, all accounting terms not otherwise defined herein shall have the meanings assigned to such terms in conformity with GAAP.
 
1.3          Other Definitional Provisions.  Any of the terms defined in Section 1.1 may, unless the context otherwise requires, be used in the singular or the plural depending on the reference.  In this Agreement, words importing any gender include the other genders; the words “including,” “includes” and “include” shall be deemed to be followed by the words “without limitation”; except as otherwise indicated (e.g., by references to agreements “as in effect as of the date hereof” or words to that effect), references to agreements and other contractual instruments shall be deemed to include subsequent amendments, assignments, and other modifications thereto, but only to the extent such amendments, assignments and other modifications are not prohibited by the terms of this Agreement or any other Loan Document; references to Persons include their respective permitted successors and assigns or, in the case of governmental Persons, Persons succeeding to the relevant functions of such Persons; and all references to statutes and related regulations shall include any amendments of same and any successor statutes and regulations.
 
SECTION 2
 
LOAN AND COLLATERAL
 
2.1          Loan.  Subject to the terms and conditions of this Agreement and in reliance upon the representations and warranties of Borrowers set forth herein and in the other Loan Documents, each Lender agrees to make a Loan to Borrowers in the principal amount of One Million Five Hundred Thousand Dollars ($1,500,000), for an aggregate amount of Loans issued hereunder equal to Three Million Dollars ($3,000,000), subject to and on the terms and conditions set forth herein.
 
2.2          Closing Date Loans.  On the Closing Date, and subject to the conditions set forth in Section 3.1(A) through Section 3.1(D) hereof, each Lender shall advance to Borrowers a Loan in an amount equal to One Million Five Hundred Thousand Dollars ($1,500,000), subject to the deduction for legal fees and expenses paid by Borrowers directly to Andrews Kurth LLP as permitted pursuant to Section 8.16.
 
2.3          Notes.  Each Loan made by a Lender to Borrowers pursuant hereto will be evidenced by a Note to be executed by Borrowers before or concurrently with Lender’s disbursement of such Loan.
 
2.4          Payments.  The principal amount of and all accrued and unpaid interest on each Loan hereunder shall be due and payable in full on the date that is set forth in the Notes (the “Maturity Date”).
 
 
-8-

 
 
2.5          Notice of Accrued Interest.  Following each calendar month, Borrowers shall prepare an Interest Statement indicating the amount of interest accrued under each outstanding Note during such calendar month, and the aggregate amount of interest accrued under each outstanding Note since the date of issuance thereof (the “Interest Statement”).  Borrowers shall deliver the Interest Statement to Lenders within seven days following the end of the prior calendar month.
 
2.6          Use of Proceeds.  The proceeds of the Loans shall be used by Borrowers solely to repurchase the Shares from the Stockholder.
 
2.7          Interest.
 
(A)           Rate of Interest.  Interest shall accrue on each Loan outstanding at a rate equal to seven percent (7%) per annum.
 
(B)           Computation and Payment of Interest.  Interest on each Loan shall be compounded on the first day of each calendar year hereafter, beginning on January 1, 2012, and shall be computed on the basis of a 360-day year for the actual number of days elapsed in the period during which it accrues.  In computing interest, the date of funding of the Loan shall be included and the date of payment of each Loan shall be excluded.  Interest shall be payable as set forth in Section 2.4 above.
 
2.8          Payments and Prepayments.
 
(A)           Manner and Time of Payment.  All payments made by Borrowers with respect to the Obligations shall be made by wire transfer in United States Dollars to each Lender’s account, without deduction, defense, setoff or counterclaim.  Lenders shall wire the Loans to Borrowers to an account specified by the Borrowers not less than two (2) Business Days prior to the Closing Date.
 
(B)           Payments on Business Days.  Whenever any payment to be made hereunder shall be stated to be due on a day that is not a Business Day, the payment may be made on the next succeeding Business Day and such extension of time shall be included in the computation of the amount of interest or fees due hereunder.
 
(C)           Prepayment.  Borrowers shall have the right to prepay, without penalty or premium, all or any portion of the outstanding balance of the Loans at any time and without the prior approval of Lenders.  In the event a portion and not the entire balance of the Loans is prepaid, Borrower shall prepay each Loan then outstanding in an equal amount.
 
(D)           Mandatory Repayment.  In the event of the occurrence of an Event of Default, or (ii) a Change of Control of Borrower, then the outstanding balance of the Loans plus accrued and unpaid interest and all other amounts then due and owing hereunder or under any other of the Loan Documents, shall be due and payable.
 
 
-9-

 
 
2.9          Grant of Security Interest.  To secure the payment and performance of the Obligations, including all renewals, extensions, restructurings and refinancings of any or all of the Obligations, each Borrower hereby assigns and grants to each Lender, a continuing first priority Lien, subject only to Permitted Encumbrances, in and to all right, title and interest of such Borrower in all assets and properties of such Borrower, whether now owned or existing or hereafter acquired or arising and regardless of where located, including the proceeds thereof (all being collectively referred to as the “Collateral”), and including, without limitation, the following property of each Borrower:
 
 
(i) 
Accounts;
 
(ii) 
Deposit Accounts (as defined in the UCC);
 
(iii) 
Documents of Title;
 
(iv) 
Equipment;
 
(v) 
General Intangibles;
 
(vi) 
Inventory;
 
(vii) 
Investment Property; and
 
(viii) 
Intellectual Property.
 
Each Borrower represents, warrants and covenants that the security interest granted herein is and shall at all times continue to be a first-priority security interest in the Collateral (subject only to Permitted Liens that may have superior priority to Lenders’ Lien under this Agreement).  If any Borrower shall acquire a commercial tort claim, such Borrower shall notify Lenders in a writing signed by such Borrower of the general details thereof and grant to Lenders in such writing a security interest therein and in the proceeds thereof, all upon the terms of this Agreement.
 
2.10        Preservation of Collateral and Perfection of Security Interests Therein.  Each Borrower shall, at any Lender’s reasonable request, at any time and from time to time, execute and deliver to such Lender within ten (10) days of such request, such financing statements, documents and other agreements and instruments and do such other acts and things as Lender may deem reasonably necessary in order to establish and maintain a valid, attached and perfected security interest in the Collateral in favor of Lender (free and clear of all other Liens, claims and rights of third parties whatsoever, whether voluntarily or involuntarily created, except Permitted Encumbrances) to secure payment of the Obligations, and in order to facilitate the collection of the Collateral.
 
2.11        Possession of Collateral and Related Matters.  Until an Event of Default has occurred and is continuing, each Borrower shall have the right, except as otherwise provided in this Agreement, in the ordinary course of such Borrower’s business, to (a) sell or lease any  Inventory normally held by such Borrower for any such purpose, (b) use and consume any raw materials, work-in-process or other materials normally held by such Borrower for such purpose, or (c) dispose of any obsolete or excess equipment in the ordinary course of business; provided, however, that a sale in the ordinary course of business shall not include any transfer or sale in satisfaction, partial or complete, of any debt owed by such Borrower.
 
2.12        Release of Security Interests.  If this Agreement is terminated, Lenders’ Lien shall continue until the Obligations are repaid in full in cash.  Upon the indefeasible payment and satisfaction in full of the Obligations, Lenders shall release all liens and security interests granted by Borrowers by execution and/or delivery of appropriate documentation, including, but not limited to, UCC termination statements, (A) within three (3) Business Days of such payment or (B) concurrently with such payment if Borrowers give three (3) Business Days advance notice of such payment.
 
 
-10-

 
 
2.13        Warrants.  As partial consideration for Lenders making the Loans to the Borrowers, Parent shall issue to each Lender at the Closing Date a Warrant to purchase up to an aggregate of Two Hundred Fifty Thousand (250,000) shares of Common Stock at a purchase price of $2.90 per share.
 
SECTION 3
 
CONDITIONS TO LOAN
 
3.1          Conditions.  The obligations of each Lender to make the Loan on the Closing Date are subject to satisfaction or waiver of each of the conditions set forth below:
 
(A)           Closing Deliveries.  Lenders shall have received this Agreement, and the Notes executed by Borrowers, and the Warrants executed by Parent.
 
(B)           Security Interests.  Lenders shall have received reasonably satisfactory evidence that all security interests and Liens granted to Lenders pursuant to this Agreement have been duly perfected and constitute valid first-priority Liens on the Collateral, with priority over all other Liens subject only to Permitted Encumbrances.
 
(C)           Representations and Warranties.  The representations and warranties contained herein shall be true, correct and complete in all material respects on and as of the Closing Date to the same extent as though made on and as of that date, except for any representation or warranty limited by its terms to a specific date.
 
(D)           No Event of Default.  No Event of Default has occurred or is continuing.
 
SECTION 4
 
BORROWERS’ REPRESENTATIONS AND WARRANTIES
 
To induce Lender to enter into this Agreement, and to fund the Loans, each Borrower represents and warrants to Lender that the following statements are true, correct and complete in all material respects with respect to Borrower making such representation or warranty as of the date hereof.  Such representations and warranties, and all other representations and warranties made by such Borrower herein or in the other Loan Documents, shall survive the execution and delivery of this Agreement and the closing contemplated hereby:
 
4.1           Authority.  Borrower is a corporation duly organized, validly existing and in good standing, under the laws of the State of Delaware.  Borrower has the power and authority to own its properties and assets and to transact the business in which is it engaged and presently proposes to engage, and has obtained all necessary and material governmental authorizations, consents and licenses in connection therewith.  Borrower has all requisite legal and corporate power and authority and has obtained all approvals and consents necessary to enter into the Loan Documents and to carry out and perform its obligations under the terms hereof and thereof.  Borrower’s execution, delivery and performance of this Agreement and the additional Loan Documents will not violate, or conflict with or constitute a default under, the terms of Borrower’s charter or Bylaws or any statute, regulation, ordinance, rule of law, agreement, contract, mortgage, indenture, bond, bill, note, judgment, order or decree of any court or arbitrator to which Borrower is a party or other instrument or writing binding upon Borrower or to which Borrower is subject.
 
 
-11-

 
 
4.2           Due Authorization; Binding Obligation.  All corporate action on the part of Borrower, its officers and directors necessary for Borrower’s authorization, execution and delivery of, and the performance of all Borrower’s obligations under, this Agreement and other Loan Documents has been taken.  Borrower has duly executed and delivered this Agreement.  This Agreement constitutes a valid and legally binding obligation of Borrower, enforceable in accordance with its terms, except as enforceability may be limited by (i) applicable bankruptcy, insolvency, reorganization or other similar laws of general application relating to or affecting the enforcement of creditors’ rights generally and (ii) the effect of rules of law governing the availability of equitable remedies.  The Notes (and, with respect to Parent, the Warrants) when executed and delivered in accordance with the terms of this Agreement, will constitute valid and legally binding obligations of Borrower and/or Parent as applicable, enforceable in accordance with their terms, except as enforceability may be limited by (i) applicable bankruptcy, insolvency, reorganization or other similar laws of general application relating to or affecting the enforcement of creditors’ rights generally and (ii) the effect of rules of law governing the availability of equitable remedies.
 
4.3           Governmental Consents.  No consent, approval, order, or authorization of or registration, qualification, designation, declaration or filing with, any Governmental Authority is required on the part of Borrower to enable Borrower to execute, deliver and perform its obligations under this Agreement or the Notes.
 
4.4           Reports and Financial Statements.  The Parent has filed all reports required to be filed with the SEC pursuant to the Exchange Act or the Securities Act of 1933 (the “Securities Act”) since May 14, 2009 (collectively, the “SEC Reports”), and has previously made available to the Lender true and complete copies of all such SEC Reports.  Such SEC Reports, as of their respective dates (or if amended or superseded by a filing prior to the date of this Agreement, then on the date of such filing), complied in all material respects with the applicable requirements of the Securities Act and the Exchange Act, as the case may be, and none of such SEC Reports (together with all other written information heretofor provided by Parent to the Lender in connection with this Agreement), as of their respective dates (or if amended or superseded by a filing prior to the date of this Agreement, then on the date of such filing), contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading.  The consolidated financial statements of Parent included in the SEC Reports have been prepared in accordance with GAAP consistently applied throughout the periods indicated (except as otherwise noted therein or, in the case of unaudited statements, as permitted by Form 10-Q of the SEC) and fairly present (subject, in the case of unaudited statements, to normal, recurring year-end adjustments and any other adjustments described therein), in all material respects, the consolidated financial position of Parent as of the dates thereof and the consolidated results of operations and cash flows of Parent for the periods then ended.  Except as disclosed in the SEC Reports there has been no change in any of the significant accounting policies or procedures of Parent since May 14, 2009.
 
 
-12-

 
 
4.5          Absence of Certain Changes or Events.  Except as set forth in the SEC Reports filed prior to the date of this Agreement, since June 30, 2011, there has not been any fact, event, circumstance or change affecting or relating to either Borrower which has had or could reasonably be expected to have a Material Adverse Effect.  The transactions contemplated by this Agreement will not require the consent from or the giving of notice to a third party pursuant to the terms, conditions or provisions of any Material Contract.
 
4.6          Litigation.  Except for litigation disclosed in the notes to the audited financial statements of Parent as of and for the period ended September 30, 2009, or in SEC Reports filed subsequent thereto but prior to the date of this Agreement, as of the date hereof, there is no suit, action, proceeding or investigation pending or, to the knowledge of Borrower, threatened against either Borrower or with respect to which either Borrower could be required to provide indemnification or to otherwise contribute to liabilities or damages relating thereto, the outcome of which has had or could reasonably be expected to have a Material Adverse Effect; nor is there any judgment, decree, injunction, rule or order of any Governmental Authority outstanding against either Borrower having, or which has had or could reasonably be expected to have, a Material Adverse Effect.
 
4.7          Compliance with Law.  Except as set forth in the SEC Reports filed prior to the date of this Agreement, Borrower has not violated any applicable laws, statutes, regulations or orders of any Governmental Authority and Borrower is in compliance with all applicable laws, statutes, regulations and order of all Governmental Authorities, other than where such violation or noncompliance, individually or in the aggregate, has not had and could not reasonably be expected to have a Material Adverse Effect.  Except as set forth in the SEC Reports filed prior to the date of this Agreement, Borrower has not received any notice to the effect that, or otherwise been advised that or is aware that, Borrower is not in such compliance with any applicable laws, statues regulations or orders of any Governmental Authority, and Borrower has no knowledge that any existing circumstances are reasonably likely to result in such violations of any applicable laws, statues regulations or orders of any Governmental Authority.
 
4.8          Absence of Undisclosed Liabilities; Ability to Pay Debts.
 
(a)           Except for liabilities or obligations which are accrued or reserved against in Parent’s consolidated financial statements (or reflected in the notes thereto) as of and for the period ended June 30, 2011 as included in the SEC Reports or which were incurred after June 30, 2011 in the ordinary course of business and consistent with past practice and otherwise permitted by this Agreement, Borrower does not have any liabilities or obligations (whether absolute, accrued, contingent or otherwise) of a nature required by GAAP to be reflected in a balance sheet (or reflected in the notes thereto) or which have had or could reasonably be expected to have a Material Adverse Effect.
 
 
-13-

 
 
(b)           As of the date of this Agreement, Borrower has not incurred and does not intend to incur, and does not believe that it will incur, debts beyond its ability to pay such debts as such debts mature and Borrower believes that it has sufficient capital with which to conduct its businesses.  For purposes of this Section 4.8(b), “debt” means any liability on a claim, and “claim” means (i) right to payment, whether or not such a right is reduced to judgment, liquidated, unliquidated, fixed, contingent, matured, unmatured, disputed, undisputed, legal, equitable, secured, or unsecured or (ii) right to an equitable remedy for breach of performance if such breach gives rise to a payment, whether or not such right to an equitable remedy is reduced to judgment, fixed, contingent, matured, unmatured, disputed, undisputed, secured or unsecured.
 
4.9          No Default.  Borrower is not in breach or violation of, or in default under (and no event has occurred which with notice or lapse of time or both would constitute such a breach, violation or default), any term, condition or provision of (a) its Certificate of Incorporation, as amended, or Bylaws, (b) the Prior Agreement or the Prior Notes, or (c) (x) except as set forth in the SEC Reports filed prior to the date of this Agreement, any order, writ, decree, statute, rule or regulation of any Governmental Authority applicable to Borrower or any of its properties or assets or (y) any agreement required to be filed as a “Material Contract” as an exhibit to the Parent’s Annual Report on Form 10-K for the year ended December 31, 2010 or any periodic Exchange Act report required to be filed since then (each a, “Material Contract”), except in the case of this clause (c), which breaches, violations or defaults, individually or in the aggregate, have not had and could not reasonably be expected to have a Material Adverse Effect.
 
4.10        Title to Properties.  Borrower has good, sufficient and legal title, to all of its properties and assets, including the Collateral.  Except for Permitted Encumbrances, all such properties and assets are free and clear of Liens.  To the knowledge of Borrower, there are no actual, threatened or alleged defaults with respect to any leases of real property under which Borrower is lessee or lessor which could reasonably be expected to have a Material Adverse Effect.  Borrower is not a party to, nor is bound by, any material license or other agreement with respect to which Borrower is the licensee (a) that prohibits or otherwise restricts Borrower from granting a security interest in Borrower’s interest in such license or agreement or any other property, or (b) for which a default under or termination of could interfere with the Lender’s right to sell any Collateral.  Borrower shall provide written notice to Lender within ten (10) days of entering or becoming bound by any such license or agreement (other than over-the-counter software that is commercially available to the public).  Borrower shall take such steps as Lender requests to obtain the consent of, or waiver by, any person whose consent or waiver is necessary for (x) all such licenses or agreements to be deemed “Collateral” and for Lender to have a security interest in it that might otherwise be restricted or prohibited by law or by the terms of any such license or agreement, whether now existing or entered into in the future, and (y) Lender to have the ability in the event of a liquidation of any Collateral to dispose of such Collateral in accordance with Lender’s rights and remedies under this Agreement and the other Loan Documents.
 
4.11        Intellectual Property.  Borrower owns, is licensed to use, or otherwise has the lawful right to use, all Intellectual Property, if any, used in or necessary for the conduct of its businesses as currently conducted, without conflict with any rights of others.
 
4.12        Brokers.  Borrower does not have any contract, arrangement or understanding with any broker, finder or similar agent with respect to the transactions contemplated by this Agreement nor has or will have any liability for any brokerage or finders’ fees or agents, commission or any similar charges in connection with this Agreement.
 
 
-14-

 
 
4.13        Investment Company.  Borrower is not an “investment company” or a company “controlled” by an “investment company,” within the meaning of the Investment Company Act of 1940, as amended.
 
4.14        Subsidiaries.  Subsidiary 1 and Subsidiary 2 are each wholly-owned subsidiaries of Parent.  Neither the Parent, Subsidiary 1 nor Subsidiary 2 have any other subsidiaries.
 
4.15        Tax Returns and Payments.  Borrower has timely filed or caused to be timely filed with the appropriate taxing authority all Federal and other material returns, statements, forms and reports for taxes (the “Returns”) required to be filed by, or with respect to the income, properties or operations of, Borrower.  The Returns accurately reflect in all material respects all liability for taxes of Borrower for the periods covered thereby.  Borrower has paid all material taxes and assessments payable by it which have become due, other than those that are being contested in good faith and adequately disclosed and fully provided for on the financial statements of Borrower in accordance with GAAP.  There is no material action, suit, proceeding, investigation, audit or claim now pending or, to the knowledge of Borrower, threatened by any authority regarding any taxes relating to Borrower.
 
4.16        Full Disclosure.  No written representation, warranty or other statement of Borrower in any certificate or written statement given to Lender, as of the date such representation, warranty, or other statement was made, taken together with all such written certificates and written statements given to Lender, contains any untrue statement of a material fact or omits to state a material fact necessary to make the statements contained in the certificates or statements not misleading.
 
SECTION 5
 
LENDER’S REPRESENTATIONS AND WARRANTIES
 
To induce Borrowers to enter into this Agreement, each Lender represents and warrants, severally and not jointly, to Borrowers that the following statements are true, correct and complete in all material respects on and as of the Closing Date.
 
5.1          Authorization of Borrowing; No Conflict.  The Lender has the power and authority to enter into this Agreement and the other Loan Documents.  The execution, delivery and performance of the Loan Documents by the Lender will have been duly authorized by all necessary action.  The execution, delivery and performance of the Loan Documents by the Lender and the consummation of the transactions contemplated by this Agreement and the other Loan Documents by the Lender, do not contravene and will not be in contravention of any applicable law, organizational documents of Lender or any agreement or order by which it or any of its property is bound.  This Agreement and the other Loan Documents, including the Notes, when executed and delivered, are and will be, the legally valid and binding obligations of the Lender, enforceable against the Lender in accordance with their respective terms except as the enforceability thereof may be limited by applicable bankruptcy, insolvency, moratorium or other similar laws effecting the enforcement of creditors rights generally and subject to any equitable principles limiting the right to obtain specific performance of any such obligation.
 
 
-15-

 
 
5.2          Investment Purposes; Accredited Investor.  The Lender (a) is acquiring the Notes for investment purposes only, for its own account, and not as nominee or agent for any other Person, and not with a view to, or for resale in connection with, any distribution thereof within the meaning of the Securities Act, (b) understands and acknowledges that the Notes have not been registered under the Securities Act or any other securities laws, (c) is not an “affiliate” (as defined in Rule 144 under the Securities Act) of the Parent, (d) has such knowledge and experience in financial and business matters as to be capable of evaluating the merits and risks of its investment, (e) is an “accredited investor” within the meaning of Rule 501 of Regulation D under the Securities Act, (f) has had the opportunity to ask questions and to receive answers from Borrowers, and to obtain information necessary to evaluate the merits and risks of this investment, and (g) understands, acknowledges and agrees that Notes have not been, and will not be, registered under (and that Parent has no present intention to register the Notes under) the Act or applicable state securities laws, and may not be sold or otherwise transferred by the Lender to a United States person unless they have been registered under the Act and applicable U.S. state securities laws or are sold or transferred in a transaction exempt therefrom.
 
SECTION 6
 
COVENANTS
 
Each Borrower covenants and agrees that until payment and performance in full of all Obligations hereunder unless Borrower has received the prior written consent of Lenders, Borrower shall perform all covenants in this Section 6.
 
6.1          Indebtedness and Liabilities.  Borrower shall not directly or indirectly create, incur, assume, guaranty, or otherwise become or remain directly or indirectly liable, on a fixed or contingent basis, with respect to any Indebtedness senior to or pari passu with the Obligations except: (a) the Obligations; (b) Capital Leases and purchase money financing for Equipment entered into in the ordinary course of business (if the leases permit granting Lenders a security interest); (c) trade payables and normal accruals in the ordinary course of business not yet due and payable or with respect to which Borrower is contesting in good faith the amount or validity thereof by appropriate proceedings and then only to the extent that Borrower has established adequate reserves therefor, if appropriate under GAAP, and (d) Permitted Indebtedness.
 
6.2          Transfers, Liens and Related Matters.
 
(A)           Transfers.  Borrower shall not sell, assign (by operation of law or otherwise) or otherwise dispose of, or grant any option with respect to any of the Collateral or other assets, except that Borrower may (i) sell Inventory and dispose of obsolete or excess Equipment in the ordinary course of business; and (ii) make other Asset Dispositions in the ordinary course of business.
 
(B)           Liens.  Except for Permitted Encumbrances, Borrower shall not directly or indirectly create, incur or assume (or agree to create, incur or assume) or permit to exist any Lien on or with respect to any of the Collateral or other assets or any proceeds, income or profits therefrom.
 
 
-16-

 
 
(C)           No Pledge Restrictions.  Borrower shall not enter into or assume any agreement (other than the Loan Documents and any document evidencing or governing Permitted Indebtedness) restricting the creation or assumption of any Lien upon any of its properties or assets, whether now owned or hereafter acquired.
 
6.3          Restricted Payments.  Except for the purchase of the Shares, Borrower shall not directly or indirectly declare, order, pay, make or set apart any sum for any Restricted Payment, except as expressly permitted in this Agreement or any other Loan Document.
 
6.4          Restriction on Fundamental Changes.  Borrower shall not: (a) undergo a Change of Control; or (b) except with thirty (30) days prior written notice to Lenders, change its jurisdiction of incorporation, type of organization (as defined in the UCC) tax, charter or other organizational number, or its legal name; or (c) acquire by purchase or otherwise all or substantially all of the assets of, or stock or other evidence of beneficial ownership, of any Person or any business division of any Person without Lenders’ prior written consent; or (d) merge into or consolidate with any other Person, except that any Subsidiary of Borrower may merge into or consolidate with Borrower or any other wholly-owned Subsidiary of Borrower; or (e) liquidate, wind up their affairs or undergo any dissolution; or (f) acquire the capital stock of any other Person for investment purposes.  Furthermore, Borrower shall not take any action that could result in the sale of all or substantially all of Borrower’s assets, or the sale, lease or other disposition of any of Borrower’s assets (including the grant of any exclusive distribution rights or other exclusive rights to Borrower’s Intellectual Property) outside the ordinary course of business.
 
6.5          Conduct of Business.  Borrower shall not engage in any business other than businesses of the type engaged in by Borrower on the Closing Date and any businesses reasonably related thereto without the prior consent of each Lender which consent shall not be unreasonably withheld, conditioned or delayed.
 
6.6          Charter Documents.  Borrower shall not (by merger, consolidation or otherwise) amend or otherwise modify its certificate of incorporation or bylaws.
 
6.7          Redemption.  Borrower shall not redeem, repurchase or otherwise acquire for value (or pay into or set aside for a sinking fund for such purpose) any shares of Common Stock or options to purchase capital stock of Parent other than (i) the repurchase of stock from employees, stockholders or other service providers pursuant to agreements to repurchase such stock at cost in connection with the termination of such employee, stockholder or other service provider providing services to Borrower, (ii) the contribution of stock by a stockholder pursuant to an agreement to contribute stock and (iii) the repurchase of the Shares from the Stockholder.
 
6.8          Proceeds.  The proceeds of the Loan shall be used in accordance with Section 2.6.
 
 
-17-

 
 
SECTION 7
 
DEFAULT, RIGHTS AND REMEDIES
 
7.1          Event of Default.  “Event of Default” means the occurrence or existence of any one or more of the following with respect to any or all of the Borrowers:
 
(A)          Payment.  Failure to make payment of any of the Obligations when due, and such failure is not be remedied within ten (10) Business Days of the applicable due date; or
 
(B)           Involuntary Bankruptcy; Appointment of Receiver, etc.  (1) A court enters a decree or order for relief with respect to Borrower or any of its properties in an involuntary case under the Bankruptcy Code or any applicable bankruptcy, insolvency or other similar law now or hereafter in effect; or (2) Subject to Section 7.1(D), the continuance of any of the following events for sixty (60) days unless dismissed or discharged:  (a) an involuntary case is commenced against Borrower, under any applicable bankruptcy, insolvency or other similar law now or hereafter in effect; or (b) a decree or order of a court for the appointment of a receiver, liquidator, sequestrator, trustee, custodian or other officer having similar powers over Borrower or over all or a substantial part of its property, is entered; or (c) an interim receiver, trustee or other custodian is appointed without the consent of Borrower for all or a substantial part of the property of any Borrower; or
 
(C)          Voluntary Bankruptcy; Appointment of Receiver, etc.  (1) An order for relief is entered with respect to Borrower or its properties or Borrower commences a voluntary case under any applicable bankruptcy, insolvency or other similar law now or hereafter in effect, or consent to the entry of an order for relief in an involuntary case or to the conversion of an involuntary case to a voluntary case under any such law or consent to the appointment of or taking possession by a receiver, trustee or other custodian for all or a substantial part of their property; or (2) Borrower makes any assignment for the benefit of creditors; or (3) the board of directors of Borrower adopts any resolution or otherwise authorizes action to approve any of the foregoing actions; or
 
(D)          Dissolution.  Any order, judgment or decree is entered against Borrower decreeing the dissolution or split up of Borrower and such order remains undischarged or unstayed for a period in excess of sixty (60) days; or
 
(E)          Failure to Repurchase the Shares.  If Parent has not purchased the Shares from the Stockholder on or before September 30, 2011; or
 
(F)          Covenant Default.
 
(a)           Borrower violates any covenant in Section 6; or
 
 
-18-

 
 
(b)           Borrower fails or neglects to perform, keep, or observe any other term, provision, condition, covenant or agreement contained in this Agreement or any Loan Document, and as to any default (other than those specified in this Section 7) under such other term, provision, condition, covenant or agreement that can be cured, has failed to cure the default within ten (10) days after Borrower becomes aware of the occurrence thereof; provided, however, that if the default cannot by its nature be cured within the ten (10) day period or cannot after diligent attempts by Borrower be cured within such ten (10) day period, and such default is likely to be cured within a reasonable time, then Borrower shall have an additional period (which shall not in any case exceed thirty (30) days) to attempt to cure such default, and within such reasonable time period the failure to cure the default shall not be deemed an Event of Default.  Grace periods provided under this section shall not apply, among other things, to any covenants set forth in subsection (a) above; or
 
(G)           Judgments.  One or more final, non-appealable judgments, orders, or decrees for the payment of money in an amount, individually or in the aggregate, of at least $25,000 (not covered by independent third-party insurance as to which liability has been accepted by such insurance carrier) shall be rendered against Borrower and shall remain unsatisfied, unvacated, or unstayed for a period of ten (10) days after the entry thereof; or
 
(H)           Misrepresentations.  Borrower or any of Borrower’s officers or directors makes any representation, warranty, or other statement in this Agreement or pursuant to this Agreement, any Loan Document or in any writing delivered to Lenders or to induce Lenders to enter this Agreement or any Loan Document, and such representation, warranty, or other statement is incorrect in any material respect when made.
 
7.2          Acceleration.  Upon the occurrence of any Event of Default, all Obligations shall automatically become immediately due and payable, without presentment, demand, protest or other requirements of any kind, all of which are hereby expressly waived by Borrower.
 
7.3          Board Representation Upon Event of Default.  Upon the occurrence of any Event of Default, other than the Event of Default in Section 7.1(E), and until such time as either all amounts owed to Lenders pursuant to the Notes have been paid in full or the Event of Default has been cured (the “Appointment Period”), the Lenders may identify to the Parent in writing one candidate (the “Lenders Designee”) to serve on the Board of Directors of Parent (the “Board”).  The Parent will promptly appoint the Lenders Designee to the Board and agrees, if necessary, to promptly take all necessary corporate action to expand the Board by one member to create a vacancy for such purpose.  Parent further agrees during the Appointment Period to promptly nominate the Lenders Designee as a member of the Board in accordance with the Securities Exchange Act of 1934 and the rules and regulations promulgated thereunder, and to solicit proxies, consents and votes in favor of such Lenders Designee serving on the Board.  The Lenders Designee will (i) be qualified to serve as a member of the Board under all applicable corporate governance policies or guidelines of Parent and the Board effective on the date of this Agreement (copies of which have been delivered to Lenders prior to the execution of this Agreement) and applicable legal, regulatory and stock market requirements, (ii) meet the standard for an “independent director” with respect to service on the Board under the Rules of The Nasdaq Stock Market (to the extent Parent’s common stock is then traded on such market) and (iii) be reasonably acceptable to the Board.  Subject to the foregoing standards, the Board will not oppose the appointment of the Lenders Designee.
 
7.4           Remedies.  If any Event of Default shall have occurred and be continuing, in addition to and not in limitation of any rights or remedies available to any Lender at law or in equity, any Lender may exercise in respect of the Collateral, in addition to all other rights and remedies provided for herein or otherwise available to it, all the rights and remedies of a secured party on default under the UCC (whether or not the UCC applies to the affected Collateral).
 
 
-19-

 
 
SECTION 8
 
MISCELLANEOUS
 
8.1          Assignment.  The provisions of this Agreement shall be binding upon and inure to the benefit of the respective successors, assigns, heirs, beneficiaries and representatives of Borrowers and Lenders; provided, however, that neither party hereto may assign or transfer any of its rights or obligations under this Agreement without the prior written consent of the other party and any prohibited assignment shall be void.
 
8.2          Amendments and Waivers.  No amendment, modification, termination or waiver of any provision of this Agreement or of the other Loan Documents, or consent to any departure by any Borrower therefrom or any of the terms, conditions, or provisions thereof, shall be effective unless the same shall be in writing and signed by Lenders and Borrowers.  Each amendment, modification, termination or waiver shall be effective only in the specific instance and for the specific purpose for which it was given.
 
8.3          Notices.  Unless otherwise specifically provided herein, all notices shall be in writing addressed to the respective party as set forth below and may be personally served, telecopied or sent by overnight courier service or United States mail and shall be deemed to have been given: (a) if delivered in person, when delivered; (b) if delivered by telecopy, on the date of transmission if transmitted on a Business Day before 4:00 p.m.  Eastern standard time or, if not, on the next succeeding Business Day; (c) if delivered by overnight courier, two (2) days after delivery to such courier properly addressed; or (d) if by U.S.  Mail, four (4) Business Days after depositing in the United States mail, with postage prepaid and properly addressed.
 
If to Borrowers:
Healthwarehouse.com, Inc.
7107 Industrial Road
Florence, KY 42042
Attention:  Lalit Dhadphale
Facsimile:  1-866-821-3784
   
If to HWH:
HWH Lending LLC
2200 Fletcher Ave., 5th Floor
Fort Lee, NJ 07024
 
Attention:  Gary Singer
 
Facsimile:  (201) 224-2762
   
If to MIL:
Milfam I L.P.
4550 Gordon Drive
Naples, FL  34102
 
Attention:  Lloyd I. Miller, III
 
Facsimile: (239) 262-8025
 
 
-20-

 
 
or to such other address as the party addressed shall have previously designated by written notice to the serving party, given in accordance with this Section 8.3.
 
8.4          Survival of Warranties and Certain Agreements.
 
(A)           All representations and warranties made hereunder and in any other Loan Document or other document delivered pursuant hereto or thereto or in connection herewith or therewith shall survive the execution and delivery hereof and thereof.  Such representations and warranties have been or will be relied upon by Lenders regardless of any investigation made by Lenders or on their behalf and notwithstanding that Lenders may have had notice or knowledge of any breach of a representation or warranty, and shall continue in full force and effect as long as any Obligation shall remain outstanding.
 
(B)           This Agreement and the Loan Documents shall remain in full force and effect until such time as the Obligations have been indefeasibly paid and satisfied in full, at which time this Agreement shall be terminated.  Notwithstanding the foregoing, this Agreement and the Loan Documents shall continue to be effective or be automatically reinstated, as the case may be, if at any time payment, in whole or in part, of any of the Obligations is rescinded or must otherwise be restored or returned by Lenders as a preference, fraudulent conveyance or otherwise, all as though such payment had not been made.
 
8.5          Indulgence Not Waiver.  No failure or delay on the part of any Lender in the exercise of any power, right or privilege shall impair such power, right or privilege or be construed to be a waiver of any default or acquiescence therein, nor shall any single or partial exercise of any such power, right or privilege preclude other or further exercise thereof or of any other right, power or privilege.
 
8.6          Entire Agreements.  This Agreement, the Notes, and the other Loan Documents referred to herein embody the final, entire agreement among the parties hereto and supersede any and all prior commitments, agreements, representations, and understandings, whether written or oral, relating to the subject matter hereof and may not be contradicted or varied by evidence of prior, contemporaneous, or subsequent oral agreements or discussions of the parties hereto.  There are no oral agreements among the parties hereto.
 
8.7          Severability.  The invalidity, illegality or unenforceability in any jurisdiction of any provision in or obligation under this Agreement or the other Loan Documents shall not affect or impair the validity, legality or enforceability of the remaining provisions or obligations under this Agreement, or the other Loan Documents or of such provision or obligation in any other jurisdiction.
 
8.8          Headings.  Section and subsection headings in this Agreement are included herein for convenience of reference only and shall not constitute a part of this Agreement for any other purpose or be given any substantive effect.
 
8.9          APPLICABLE LAW.  THIS AGREEMENT AND ALL MATTERS RELATING HERETO AND ARISING HEREFROM (WHETHER ARISING UNDER CONTRACT LAW, TORT LAW OR OTHERWISE) SHALL BE GOVERNED BY, AND SHALL BE CONSTRUED AND ENFORCED SOLELY AND EXCLUSIVELY IN ACCORDANCE WITH, THE INTERNAL LAWS OF THE STATE OF NEW YORK WITHOUT REGARD TO CONFLICTS OF LAWS PRINCIPLES.
 
 
-21-

 
 
8.10        CONSENT TO JURISDICTION.  EACH PARTY HERETO HEREBY IRREVOCABLY CONSENTS TO THE SOLE AND EXCLUSIVE JURISDICTION OF ANY STATE OR FEDERAL COURT LOCATED WITHIN THE COUNTY OF NEW YORK, STATE OF NEW YORK, AND IRREVOCABLY AGREES THAT ALL ACTIONS OR PROCEEDINGS ARISING OUT OF OR RELATING TO THIS AGREEMENT, THE NOTES, THE WARRANTS OR THE OTHER LOAN DOCUMENTS SHALL BE LITIGATED SOLELY AND EXCLUSIVELY IN SUCH COURTS.  EACH PARTY HERETO ACCEPTS FOR ITSELF AND IN CONNECTION WITH ITS PROPERTIES, GENERALLY AND UNCONDITIONALLY, THE EXCLUSIVE JURISDICTION OF THE AFORESAID COURTS AND WAIVES ANY DEFENSE OF FORUM NON CONVENIENS, AND IRREVOCABLY AGREES TO BE BOUND BY ANY JUDGMENT RENDERED THEREBY IN CONNECTION WITH THIS AGREEMENT, THE NOTES, THE WARRANTS, THE OTHER LOAN DOCUMENTS OR THE OBLIGATIONS.  IF ANY PARTY HERETO PRESENTLY IS, OR IN THE FUTURE BECOMES, A NONRESIDENT OF THE STATE OF NEW YORK, EACH PARTY HERETO HEREBY WAIVES PERSONAL SERVICE OF ANY AND ALL PROCESS AND AGREES THAT ALL SUCH SERVICE OF PROCESS MAY BE MADE UPON SUCH PERSON BY CERTIFIED OR REGISTERED MAIL, RETURN RECEIPT REQUESTED, DIRECTED TO SUCH PERSON, AT SUCH PERSON’S ADDRESS AS SET FORTH IN SECTION 8.3 HEREOF OR AS MOST RECENTLY NOTIFIED BY SUCH PERSON IN WRITING PURSUANT TO SECTION 8.3 AND SERVICE SO MADE SHALL BE COMPLETE TEN (10) DAYS AFTER THE SAME HAS BEEN POSTED AS AFORESAID.
 
8.11        WAIVER OF JURY TRIAL.  EACH PARTY HERETO HEREBY WAIVES THEIR RESPECTIVE RIGHTS TO A JURY TRIAL OF ANY CLAIM OR CAUSE OF ACTION BASED UPON OR ARISING OUT OF THIS AGREEMENT, THE TERM NOTES OR THE OTHER LOAN DOCUMENTS.  EACH PARTY HERETO ACKNOWLEDGES THAT THIS WAIVER IS A MATERIAL INDUCEMENT TO ENTER INTO A BUSINESS RELATIONSHIP, THAT EACH HAS ALREADY RELIED ON THE WAIVER IN ENTERING INTO THIS AGREEMENT, THE TERM NOTES AND THE OTHER LOAN DOCUMENTS AND THAT EACH WILL CONTINUE TO RELY ON THE WAIVER IN THEIR RELATED FUTURE DEALINGS.  EACH PARTY HERETO FURTHER WARRANTS AND REPRESENTS THAT EACH HAS REVIEWED THIS WAIVER WITH ITS LEGAL COUNSEL, AND THAT EACH KNOWINGLY AND VOLUNTARILY WAIVES ITS JURY TRIAL RIGHTS FOLLOWING CONSULTATION WITH LEGAL COUNSEL.
 
8.12        Construction.  Each Borrower and each Lender acknowledges that it has had the benefit of legal counsel of its own choice and has been afforded an opportunity to review this Agreement and the other Loan Documents with its legal counsel and that this Agreement and the other Loan Documents shall be construed as if jointly drafted by Borrowers and Lenders.
 
 
-22-

 
 
8.13        Counterparts; Effectiveness.  This Agreement and any amendments, waivers, consents, or supplements may be executed in any number of counterparts and by different parties hereto in separate counterparts, each of which when so executed and delivered shall be deemed an original, but all of which counterparts together shall constitute but one and the same instrument.  This Agreement shall become effective upon the execution of a counterpart hereof by each of the parties hereto.  Delivery of an executed counterpart of a signature page to this Agreement, any amendments, waivers, consents or supplements, or to any other Loan Document by facsimile or email shall be as effective as delivery of a manually executed counterpart thereof.
 
8.14        Confidentiality.  For the purposes of this Section 8.14, “Confidential Information” means all financial and other information delivered to Lenders by or on behalf of Borrowers in connection with the transactions contemplated by or otherwise pursuant to this Agreement that is proprietary in nature or that is clearly marked or labeled (or otherwise adequately identified) as being confidential information of any Borrower, provided, that such term does not include information that (a) was publicly known prior to the time of such disclosure, (b) subsequently becomes publicly known through no act or omission by any Lender or any Person acting on its behalf, (c) otherwise becomes publicly known other than through disclosure by any Borrower, or (d) constitutes financial statements delivered hereunder that are otherwise publicly available.  Lenders will maintain the confidentiality of such Confidential Information in accordance with commercially reasonable procedures adopted by Lenders in good faith to protect confidential information of third parties delivered to them; provided, that a Lender may deliver or disclose Confidential Information to:
 
(i)           its directors, officers, employees, agents, attorneys and affiliates, to the extent such disclosure reasonably relates to the administration of the Loan, and further provided that each such recipient of Confidential Information agrees in writing provided to any Borrower, to keep such information confidential;
 
(ii)          its financial advisors and other professional advisors who are advised to hold confidential the Confidential Information; or
 
(iii)         any other Person (including auditors and other regulatory officials) to which such delivery or disclosure may be necessary or appropriate (A) to comply with any applicable law, rule, regulation or order, (B) in response to any subpoena, examination, or other legal process, (C) in connection with any litigation to which Lender is a party.
 
8.15        Time of Essence.  Time is of the essence for the performance of all Obligations set forth in this Agreement.
 
8.16        Attorneys’ Fees and Expenses.  The Borrowers shall pay all costs and expenses that they incur with respect to the negotiation, execution, delivery, and performance of the Loan Documents.  If the Closing is effected, the Borrowers shall pay the reasonable and actual out-of pocket attorney’s fees and expenses of Andrews Kurth LLP, legal counsel to the Lenders, incurred in connection with the negotiation, execution and delivery of the Loan Documents, not to exceed $12,000.00.  Borrowers hereby authorize the lenders to pay such amounts directly to Andrews Kurth LLP by deducting such amounts from the amount loaned to the Borrowers at Closing.  If any action is instituted concerning or arising out of this Agreement or any transaction contemplated under this Agreement, the prevailing party shall recover all of such party’s costs and attorneys’ fees incurred in each such action, suit, or other proceeding, including any and all appeals or petitions from such action, suit, or other proceeding.
 
 
-23-

 
 
 [This space intentionally left blank – signature page follows.]
 
 
-24-

 

Witness the due execution hereof by the respective duly authorized officers of the undersigned as of the date first written above.

HWH:
HWH Lending LLC
   
 
By:
/s/ Gary Singer
 
Name:  Gary Singer
Title:  President
   
MIL:
Milfam I, L.P.
   
 
By:  Milfam LLC
 
its General Partner
   
 
By:
/s/ Lloyd I. Miller, III 
 
Name:  Lloyd I. Miller, III
Title:  Manager
 
Signature Page to Loan and Security Agreement
 
 

 
 
PARENT:
Healthwarehouse.com, Inc.
   
 
By:
/s/ Lalit Dhadphale
 
Name:  Lalit Dhadphale
Title:  President & CEO
 
SUBSIDIARY 1:
HWAREH.com, Inc.
   
 
By:
/s/ Lalit Dhadphale
 
Name:  Lalit Dhadphale
Title:  President & CEO
   
SUBSIDIARY 2:
Hocks.com, Inc.
   
 
By:
/s/ Lalit Dhadphale
 
Name:  Lalit Dhadphale
Title:  President & CEO
 
Signature Page to Loan and Security Agreement
 
 

 

Schedule A

Existing Indebtedness

None
 
Signature Page to Loan and Security Agreement
 
 

 
EX-10.2 7 v234141_ex10-2.htm EXHIBIT 10.2

EXHIBIT 10.2

EXECUTION COPY
STOCK PURCHASE AGREEMENT

This Stock Purchase Agreement (the “Agreement”) is made as of September 2, 2011, by and among Rock Castle Holdings, LLC, an Ohio limited liability company (the “Seller”) and Healthwarehouse.com, Inc., a Delaware corporation (the “Purchaser”).

RECITALS

WHEREAS, the Seller is the record and beneficial owner of shares of common stock, $0.001 par value per share (the “Common Stock”), of the Purchaser; and

WHEREAS, the Seller desires to sell that number of shares of Common Stock of the Purchaser set forth next to its name on Schedule 1 hereto (collectively, the “Shares”), and the Purchaser desires to purchase such number of Shares set forth next to its name on Schedule 2 hereto, for the consideration set forth below and subject to all of the terms, conditions, promises, representations and warranties set forth herein.

AGREEMENT
 
NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto hereby agree as follows:
 
1.              Sale and the Shares.  Subject to the terms and conditions of this Agreement, at the Closing (as hereinafter defined), the Seller hereby agrees that it shall sell, assign, transfer, convey and deliver the Shares to the Purchaser.
 
2.              Payment by the Purchasers.  Subject to the terms and conditions of this Agreement, at the Closing, the Purchaser hereby agrees to purchase the Shares from the Seller for the Purchase Price. At the Closing, the Purchaser shall pay to the Seller cash in the total amount of the Purchase Price by wire transfer in immediately available funds to such account as the Seller shall designate in writing. The term “Purchase Price” shall mean an amount equal to $2.90 per Share multiplied by the number of Shares being sold by the Seller and the aggregate Purchase Price to be paid by the Purchaser to the Seller for the Shares shall be $3,419,714.80.
 
3.              Closing.   The Closing of the sale to, and purchase by, the Purchaser of the Shares (the “Closing”) shall occur at the offices of Kohnen & Patton LLP, 201 East Fifth St., Suite 800, Cincinnati, OH 45202 on the date hereof, or such later date as the Seller and the Purchaser may agree (the “Closing Date”).

4.              Representations & Warranties of Seller.  The Seller hereby represents and warrants to the Purchaser as of the date hereof and as of the Closing Date, that

(a)         The Seller has all necessary power and authority under all applicable provisions of applicable law to execute and deliver this Agreement and to carry out the provisions hereof. All action on the Seller’s part required for the lawful execution and delivery of this Agreement has been taken as of the date hereof.

 
 

 

(b)         This Agreement has been duly and validly executed and delivered by the Seller, and constitutes the valid and binding agreement of the Seller, enforceable against the Seller in accordance with its terms, except (i) as limited by applicable bankruptcy, insolvency, reorganization, moratorium or other laws of general application affecting enforcement of creditors’ rights, and/or (ii) as limited by general principles of equity that restrict the availability of equitable remedies.

(c)         The execution, delivery and performance of this Agreement by the Seller will not: (i) contravene any law, rule or regulation of any state or of the United States, or any order, writ, judgment, injunction, decree, determination or award, or cause the suspension or revocation of any authorization, consent, approval or license, presently in effect that affects or binds the Seller; or (ii) conflict with or result in a material breach of or default under any indenture or loan or credit agreement or any other agreement or instrument to which the Seller is a party or by which the Seller or its properties may be affected or bound.

(d)         The number of Shares set forth next to the Seller’s name on Schedule 1 hereto are owned of record and beneficially by the Seller free and clear of any and all restrictions on transfer (other than restrictions on transfer under applicable state and federal laws), taxes, liens, encumbrances, options, warrants, purchase rights, contracts, commitments, equities, claims, and demands; and the Seller is not a party to any option, warrant, purchase right, or other contract or commitment that could require the Seller to sell, transfer, or otherwise dispose of its Shares (other than pursuant to this Agreement).

(e)         The Stock Power Separate from Certificate (defined below) and the other instruments executed and delivered by the Seller to the Purchaser pursuant to Section 7.1(d) will be valid and binding obligations of the Seller, enforceable in accordance with their respective terms, and will effectively vest in the Purchaser good, valid and marketable title to the Shares to be transferred by the Seller to the Purchaser pursuant to and contemplated by this Agreement, free and clear of all encumbrances whatsoever, other than those that may be created by the  Purchaser.

(f)         The Seller has not relied upon any representation or other information from the Purchaser (whether oral or written) with respect to the Purchaser other than as set forth in this Agreement.

(g)         The Seller has adequate information concerning the business and financial condition of the Purchaser to make an informed decision regarding the sale of its Shares and has independently and without reliance upon the Purchaser or its agents made its own analysis and decision to sell the Shares.

5.              Representations & Warranties or Purchaser. The Purchaser hereby represents and warrants to the Seller as of the date hereof and as of the Closing Date, that:

 
2

 

(a)         The Purchaser has all necessary power and authority under all applicable provisions of law to execute and deliver this Agreement and to carry out the provisions hereof. All action on the Purchaser’s part required for the lawful execution and delivery of this Agreement has been taken as of the date hereof.

(b)         This Agreement has been duly and validly executed and delivered by the Purchaser, and constitutes the valid and binding agreement of the Purchaser, enforceable against the Purchaser in accordance with its terms, except (i) as limited by applicable bankruptcy, insolvency, reorganization, moratorium or other laws of general application affecting enforcement of creditors’ rights, and/or (ii) as limited by general principles of equity that restrict the availability of equitable remedies.

(c)         The execution, delivery and performance of this Agreement by the Purchaser will not: (i) contravene any law, rule or regulation of any state or of the United States, or any order, writ, judgment, injunction, decree, determination or award, or cause the suspension or revocation of any authorization, consent, approval or license, presently in effect that affects or binds the Purchaser; or (ii) conflict with or result in a material breach of or default under any indenture or loan or credit agreement or any other agreement or instrument to which the Purchaser is a party or by which the Purchaser or its properties may be affected or bound.

(d)         [RESERVED]

(e)         The Purchaser has adequate information concerning the business and financial condition of the Purchaser to make an informed decision regarding the purchase of Common Stock and independently and without reliance upon the Seller or its agents has made its own analysis and decision to purchase the number of Shares set forth next to its name on Schedule 2 hereto.

(f)         The Purchaser is sophisticated and experienced in evaluating the merits and risks involving an investment in Common Stock. Purchaser has the ability to bear the economic risks of its purchase of Common Stock and has independently and without reliance upon the Seller or its agents made its own analysis and decision to acquire the Shares set forth next to its name on Schedule 2 hereto.

(g)         The Purchaser’s address set forth on the signature page hereto represents the Purchaser’s true and correct state of domicile upon which the Seller may rely for the purpose of complying with any applicable state securities laws.

6.              Additional Acknowledgements & Covenants by the Seller. The Seller further acknowledges and agrees that the Purchaser may now possess nonpublic information concerning the Purchaser not known to the Seller, including, without limitation, information which the Purchaser may have received on a confidential basis or information received from other sources (the “Confidential Information”). Such Confidential Information may include certain forecasts and projections and information relating to the transactions the Purchaser may be conducting. The Confidential Information may or may not be material, may or may not have been publicly disclosed by or on behalf of the Purchaser, and may or may not be available to the Seller from sources other than the Purchaser. The Seller acknowledges that such information may be material to the Seller’s decision to sell the Shares, and that if such information was made known to the Seller, it could cause the Seller to not proceed with, or delay the timing of, the sale of its Shares, or could cause the Seller to change the terms and conditions, including the Purchase Price, of the sale of its Shares. The Seller, on behalf of itself and its directors, officers, trustees, shareholders, employees, beneficiaries, attorneys, agents, representatives, partners, limited partners, investors, affiliates, heirs, successors and assigns, to the maximum extent permitted by applicable law, hereby:

 
3

 

(i)            agrees that neither the Purchaser nor any of its affiliates nor any of Purchaser’s or its affiliates’ respective current or former directors, officers, managers, members, partners (general or limited), employees, beneficiaries, attorneys, agents or representatives (collectively, the “Purchaser Released Parties”) shall have any liability to the Seller or its current or former directors, officers, trustees, employees, beneficiaries, attorneys, agents, representatives, partners, limited partners, investors, heirs, shareholders, with respect to, based upon, arising from, resulting from, or relating to directly or indirectly the existence, substance, possession, disclosure, or nondisclosure of any Confidential Information whatsoever, whether arising directly or indirectly, primarily or secondarily, by contract or operation of law or otherwise, including, without limitation, as a matter of contribution, indemnification, set-off, rescission, or reimbursement;

(ii)            waives, to the maximum extent permitted by law, any right, claim or cause of action at law or in equity with respect to, arising from, based upon, resulting from or relating to directly or indirectly the existence, substance, possession, disclosure or nondisclosure of any Confidential Information, including, without limitation, pursuant to Sections 10(b) and 20A of the Securities Exchange Act of 1934 as amended (the “Exchange Act”), or the rules and regulations promulgated by the Securities and Exchange Commission under the Exchange Act, or of any state statute or regulation, and relinquishes all rights and remedies accorded by applicable law to a purchaser of securities with respect to the Shares to the maximum extent permitted by law, as well as all rights to participate in any claim, action or remedy others may now or hereafter have with respect to the foregoing; and

(iii)            forever releases and discharges the Purchaser Released Parties of and from any and all suits, demands, obligations, liabilities, claims and causes of action, contingent or otherwise, of every kind and nature, at law and in equity, whether asserted, unasserted, absolute, contingent, known or unknown, which the Seller or its directors, officers, trustees, shareholders, employees, beneficiaries, attorneys, agents, representatives, partners, members, limited partners, investors, affiliates, heirs, successors and/or assigns may have against the Purchaser Released Parties, or any of them, to the extent arising from, relating to, based upon, resulting from, relating to directly or indirectly, or in connection with the existence, substance, possession, disclosure or nondisclosure of any Confidential Information.

 (iv)            waives any and all protections afforded by any state or federal statute or regulation that would, if enforced, have the effect of limiting the enforceability or effectiveness of the foregoing releases or other foregoing provisions of this Agreement.

 
4

 

 6A           Additional Acknowledgements by the Purchaser.

The Purchaser acknowledges and agrees that (i) the Purchaser granted the Seller a Non-Qualified Stock Option (the “Option”) under the terms of the Purchaser’s 2009 Incentive Compensation on May 20, 2009 to purchase 250,000 shares of Common Stock at a purchase price of $2.00 per share (post-reverse stock split), and (ii) as of the Closing Date, the Option remains in full force and effect.  Nothing in this Agreement shall be deemed to modify or amend the terms of the Option.

7.              Conditions to Purchase and Sale of the Shares.

7.1      Conditions to Obligations of Purchaser. The obligations of the Purchaser to purchase the Shares are subject to the fulfillment or waiver of each of the following conditions on or before the Closing Date:

(a)         Representations and Warranties. The representations and warranties of the Seller contained in Section 4 shall be true and correct in all respects on and as of the Closing Date, with the same effect as though such representations and warranties had been made on and as of such date.
(b)         Performance. The Seller shall have performed and complied with all covenants, agreements, obligations and conditions contained in this Agreement that are required to be performed or complied with by the Seller on or before the Closing Date.

(c)         Stock Certificates and Transfer Powers. The Seller shall deliver to the Purchasers at the Closing stock certificates representing the Shares along with a duly executed stock power separate from certificate (the “Stock Power Separate from Certificate”) in the form attached hereto as Exhibit A evidencing the transfer of the Shares, dated as of the Closing Date, as shall be effective to vest in the Purchaser good and marketable title to the Shares.  The signature of the Seller on the Stock Power Separate from Certificate must be Medallion Guaranteed.

(d)         [Reserved]

(e)         [Reserved]

(f)         No Suspension of Trading in Common Stock. Trading in the Common Stock shall not have been suspended (or threatened to be suspended) by the Securities and Exchange Commission or the principal market on which the Common Stock is listed or quoted for trading (the “Trading Market”), at any time since the date of execution of this Agreement, and the Common Stock shall have been at all times since such date listed for trading on the Trading Market.

7.2           Conditions to Obligations of Seller. The obligations of the Seller to sell the Shares is subject to the fulfillment or waiver of each of the following conditions on or before the Closing Date:

 
5

 

(a)           Representations and Warranties. The representations and warranties of the Purchaser contained in Section 5 shall be true and correct in all respects on and as of the Closing Date, with the same effect as though such representations and warranties had been made on and as of such date.

(b)           Performance. The Purchaser shall have performed and complied with all covenants, agreements, obligations and conditions contained in this Agreement that are required to be performed or complied with by the Purchaser on or before the Closing Date.

(c)           Payment of the Purchase Price. The Purchaser shall have delivered the consideration specified in Section 2.

(d)           Payment of Accounts Receivable. The Purchaser shall have paid Masters Health Care LLC (“MHC”) the sum of $62,565.96, and Masters Pharmaceutical, Inc. (“MP”) the sum of $404,268.73 (the “Accounts Receivable”) contemporaneously with the Closing. In addition, the Purchaser shall transfer the sum of $77,338.79 (the "Return Escrow") to the trust account of its attorney, Kohnen & Patton, LLP, contemporaneously with the Closing.  The Return Escrow shall be held in trust by Kohnen & Patton, LLP until such time as MHC and MP shall have determined the value of certain products being returned to MHC and MP by the Purchaser.  Once the value of the returned products is determined, Kohnen & Patton, LLP shall disburse the Return Escrow to the parties as directed by MHC and MP.  MHC and MP are affiliates of the Seller and the Accounts Receivable and Return Escrow (once disbursed) represent all net amounts owed by the Purchaser to MHC and MP as of the Closing Date for pharmaceuticals and healthcare supplies, and all net amounts owed by MHC and MP to the Purchaser.  At the closing, the Purchaser shall pay the Accounts Receivable and the Return Escrow in cash by wire transfer of immediately available funds to such accounts as the Seller shall designate in writing.

8.             Miscellaneous.

(a)           Governing Law. This Agreement and all acts and transactions pursuant hereto and the rights and obligations of the parties hereto shall be governed, construed and interpreted in accordance with the laws of the State of Delaware, without giving effect to principles of conflicts of law.

(b)           Entire Agreement; Enforcement of Rights; Amendment. This Agreement, together with any appendices hereto, sets forth the entire agreement and understanding of the parties relating to the subject matter herein and merges all prior discussions between them. No modification of or amendment to this Agreement, nor any waiver of any rights under this Agreement, shall be effective unless in writing signed by the parties to this Agreement. The failure by a party to enforce any rights under this Agreement shall not be construed as a waiver of any rights of such party. No amendment or waiver of this Agreement will be effective with respect to any party unless made in writing and signed by the parties hereto.

 
6

 

(c)           Construction. This Agreement is the result of negotiations between and has been reviewed by each of the parties hereto and their respective counsel, if any; accordingly, this Agreement shall be deemed to be the product of all of the parties, and no ambiguity shall be construed in favor of or against any one of the parties.

(d)           Counterparts; Originals. This Agreement may be executed in one or more counterparts and by PDF or facsimile, each of which shall be deemed an original and all of which together shall constitute one instrument.

(e)           Consultation with Advisors. The Seller and the Purchaser acknowledge and agree that they each had a full and complete opportunity to consult legal, tax and business advisors and has in fact consulted such advisors with respect to this Agreement and any matters hereunder to the extent it has deemed appropriate.

(f)           Publicity. Neither the Purchaser nor the Seller shall issue or cause the publication of any press release or other public announcement with respect to this Agreement and the transactions contemplated hereby without the express prior written consent of the other party, such consent not to be unreasonably withheld. Notwithstanding the foregoing, the parties acknowledge that the other parties may make any press release or similar announcement reasonably required so as to allow such party or any of its affiliates to comply with the disclosure requirements of any applicable securities laws.

(g)           Attorneys’ Fees. If any action at law or in equity is necessary to enforce or interpret the terms of this Agreement, the prevailing party shall be entitled to reasonable attorneys’ fees, costs and necessary disbursements in addition to any other relief to which such party may be entitled.

(h)           Delays or Omissions. No delay or omission to exercise any right, power or remedy accruing to any party under this Agreement, upon any breach or default of any other party under this Agreement, shall impair any such right, power or remedy of such non-breaching or non-defaulting party nor shall it be construed to be a waiver of any such breach or default, nor an acquiescence therein, nor a waiver of or acquiescence in any similar breach or default thereafter occurring; nor shall any waiver of any single breach or default be deemed a waiver of any other breach or default theretofore or thereafter occurring. Any waiver, permission, consent or approval of any kind or character on the part of any party of any breach or default under this Agreement, or any waiver on the part of any party of any provisions or conditions of this Agreement, must be in writing and shall be effective only to the extent specifically set forth in such writing. All remedies, either under this Agreement or by law or otherwise afforded to any party, shall be cumulative and not alternative.

(i)           Notices.          Unless otherwise provided, any notice required or permitted under this Agreement shall be in writing and shall be deemed to have been duly given and received: (i) on the date of personal service thereof; (ii) on the third business day after mailing, if the notice is mailed by registered or certified mail; (iii) one business day after being sent by professional or overnight courier or messenger service guaranteeing overnight delivery, with receipt confirmed by the courier; or (iv) on the date of transmission if sent by facsimile or by such other means of electronic transmission resulting in written copies, with receipt confirmed. Any such notice shall be delivered or addressed to the parties at the addresses set forth on the signature pages hereto or at the most recent address specified by the addressee through written notice under this Section 8(i). Failure to conform to the requirements that mailings be done by one of the above-specified methods shall not defeat the effectiveness of notice actually received by the addressee.

 
7

 

(j)           Severability.          If one or more provisions of this Agreement are held to be unenforceable under applicable law, such provision shall be excluded from this Agreement and the balance of the Agreement shall be interpreted as if such provision were so excluded and shall be enforceable in accordance with its terms.

(k)           Specific Performance.          The parties agree that irreparable damage would occur in the event that any of the provisions of this Agreement were not performed in accordance with their specific terms. It is accordingly agreed that the parties shall be entitled to seek specific performance of the terms hereof, this being in addition to any other remedies to which they are entitled at law or equity.

(l)           Successors and Assigns.          The terms of this Agreement shall inure to the benefit of and be binding upon the parties hereto and their respective successors and assigns; provided, however, this Agreement will be assignable by Purchaser only with the prior written consent of Seller.

(m)           Survival.          Each of the representations and warranties, covenants and agreements, set forth in this Agreement shall survive the Closing under this Agreement.

(n)           Dispute Resolution.          Any dispute, controversy or claim arising out of or relating to this Agreement or the breach, termination, enforcement, interpretation or validity thereof, including the determination of the scope or applicability of this agreement to arbitrate, shall be resolved exclusively through binding arbitration by a single arbitrator. The arbitration shall be administered by JAMS pursuant to its Comprehensive Arbitration Rules & Procedures in effect at the time the demand for arbitration is made. The arbitration called for herein shall be held at the Washington D.C. office of JAMS or, if such proceeding cannot be lawfully held in such location, as near thereto as applicable law permits. Notwithstanding the foregoing, nothing herein shall prevent a party from seeking a preliminary injunction or other form of provisional relief with respect to any dispute, controversy or claim arising out of or relating to the Agreement or the breach, termination, enforcement, interpretation or validity thereof.

(o)           Word Usage.          Unless the context of this Agreement clearly requires otherwise, (a) the masculine, feminine, and neuter genders shall each be deemed to include the others; (b) “shall,” “will,” “must,” or “agrees” are mandatory, and “may” is permissive; (c) “or” is not exclusive; and (d) “includes” and “including” are not limiting.

 
8

 

(p)           Further Assurances.  Each party shall do and perform, or cause to be done and performed, all such further acts and things, and shall execute and deliver all such other agreements, certificates, instruments and documents, as any other party may reasonably request in order to carry out the intent and accomplish the purposes of this Agreement and the consummation of the transactions contemplated hereby, including, with respect to Seller, execution, acknowledgement and delivery of all further assignments, transfers and any other such instruments of conveyance, upon the reasonable request of the Purchaser, to confirm the sale of the Shares hereunder.

(q)           Transaction Expenses.  The parties shall be responsible for their own fees and expenses related to the transactions contemplated by this Agreement.
 
[remainder of page intentionally left blank; signature pages follow]

 
9

 

EXHIBIT 10.2

            IN WITNESS WHEREOF, the parties hereto have executed this Stock Purchase Agreement as of the date first set forth above.

 
  
“PURCHASER”:
   
     
 
  
HEALTHWAREHOUSE.COM, INC.
   
     
 
  
/s/ Lalit Dhadphale   
   
 
  
By:       Lalit Dhadphale
             President & CEO
   
     
Purchaser Address for
Notices:
  
7107 Industrial Road
Florence, KY 42042
Tel:  1-866-885-0508
Fax:  1-866-821-3784
   
 
Purchaser Signature Page to SPA

 
 

 

IN WITNESS WHEREOF, the parties have executed this Stock Purchase Agreement as of the date first written above.

 
  
“SELLER”:
  
 
     
 
  
ROCK CASTLE HOLDINGS LLC
  
 
       
 
  
By:
  
 /s/ Dennis Smith   
  
 
 
  
Name:
  
           Dennis Smith
  
 
 
  
Title:
  
            Sole Member
  
 

Seller Address for
Notices:
  
 
  
 
  
 
 
  
 
  
 
  
 
 
  
 
  
 
  
 
 
  
 
  
 
  
 
 
Purchaser Signature Page to SPA

 
 

 
 
SCHEDULE 1
 
SELLER AND SHARES TO BE SOLD

Name of Seller
 
Share Certificate
Number/s
 
Number of Shares
to be Sold
   
Purchase Price
 
Rock Castle Holdings LLC
 
 
    1,179,212     $ 3,419,714.80  
                     
Total:
        1,179,212     $ 3,419,714.80  

 
 

 

SCHEDULE 2
 
PURCHASERS AND SHARES TO BE PURCHASED

Name of Purchaser
 
Number of Shares
to be Purchased
   
Purchase Price
 
HealthWarehouse.com, Inc.
    1,179,212     $ 3,419,714.80  
                 
Total:
    1,179,212     $ 3,419,714.80